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ABSTRACT
Researchers in visualisation and diagnostic imaging for biological applications regard 
water soluble fluorescent dendrimers as potentially useful materials. Described in this 
thesis is research with the aim o f  preparing and investigating a new series o f  
fluorescent polyamidoamine (PAMAM) dendrons with an imidazole naphthalimide 
derivative (i.e. 7//-benz[Je]benzim idazo[2,l-a]isoquinoline-7-one ) as the fluorescent 
core.
After an introduction to the use o f  dendrimers and dendritic compounds in biology 
(Chapter 1), we describe work to prepare and optimise potential fluorophore cores, 
which are based on A-alkylamino, vV-arylamino or imidazole naphthalimide 
derivatives (Chapter 2). The fluorescence intensity o f  most o f these aromatic systems 
is weak due to the efficient intramolecular photoinduced electron transfer process 
(PET). However, derivatives o f  7//-benz[Je]benzim idazo[2,l-a]isoquinoline-7-one 
proved encouraging and it was decided to use this readily modifiable fluorophore as 
the core in the design o f  highly fluorescent dendrons.
In the second experimental part o f the thesis (Chapter 3), we designed and prepared 
several new water soluble fluorescent PAMAM dendrons based on 7H- 
benz[^]benzim idazo[2,l-a]isoquinoline-7-one as fluorescent core and studied their 
photochemical and physicochemical properties. The dendrons are all fluorescent due 
to the core but in some cases this is modulated by the PET process, which increases 
with higher PAMAM dendron generation. For all dendrons the fluorescence is 
linearly correlated with concentration and the pH o f  the aqueous solvent has a 
significant effect for both UV absorbance (ground state) and fluorescent emission 
(excited state). In strong acidic media this is due to protonation o f the core, while in
V
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basic media the fluorescent emission is quenched due to presence of'the PET process 
involving the tertiary amine groups within the PAMAM units. The strongest 
fluorescent emission o f  all carboxy late-terminated dendrons was pH 6. 
Physicochemical studies using the Pulsed Gradient Spin Echo Nuclear Magnetic 
Resonance (PGSE-NM R) technique indicate that the self-diffusion coefficient and 
hydrodynamic radii are unaffected by concentration suggesting that there is no 
aggregation. The confirmed properties (i.e. water solubility, high fluorescence at near 
neutral pH, and no aggregation) suggest these new dendrons are promising for 
applications in biological studies.
The next part o f  the thesis describes new avenues o f research using these dendrons 
and similar materials are suggested in the final chapter (Chapter 5).
Finally, the appendix part o f the thesis describes experimental work to assess the 
transport o f  the dendrons through biological barriers and their binding to DNA 
(Appendix A). This work was carried out in collaboration with other research groups. 
Initial studies suggest that the permeability o f  fluorescent core PAMAM dendrons 
across MDCK cell monolayers appear to be a function o f  the size o f  the dendrons. 
These studies pave the way for future detailed mechanistic and morphological studies 
to elucidate the nature o f  the interaction o f  fluorescent core PAMAM dendrons with 
epithelial cells. Preliminary studies also show that the fluorescent core binds to DNA, 
presumably by intercalation o f  the aromatic core. Addition o f  negatively charged 
dendrons results in a strong decrease in affinity for DNA. The affinity is not restored 
by esterification, highlighting contributions o f  both electrostatic repulsion but 
particularly steric interactions in blocking interactions. Coupling the fluorescent core
VI
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to positively charged dendrons leads to strong binding accompanied by precipitation 
o f  the DNA complex.
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OR Literally = "in life" ie in a living animal or human.
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'antibonding' n orbital designated as n*.
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Papp apparent permeability coefficients
PAMAM polyamidoamine
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PET photoinduced electron transfer process
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tt-tt* An electronic transition described approximately as a promotion of
t ra n s it io n  an electron from a 'bonding' n orbital to an 'antibonding' n orbital
designated as n*
Q  The ohm (symbol: Q) is the S[ unit of electrical resistance
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Chapter One: Introduction
1.1. Dendrimers
1.1.1. Background
Dendrimers can be considered one o f  the more attractive recent discoveries in the 
field o f  organic and polymer synthesis. They are exciting because they have an 
exceptional three-dimensional structure comprising three distinct components: core 
(or focal point), branching point and periphery (Figure 1.1). The story o f  the 
development o f  dendrimers starts in 1978 when V6gtlet,] reported his first steps 
towards an iterative synthesis o f  “cascade molecules” with branched architectures. 
Two distinct synthetic approaches are now established for these three-dimensional 
macromolecules; Tomalia et al. pioneered the divergent synthesis involving an 
“inside-out” approach,[2'3] while Hawker and Fr6chet[4] pioneered convergent 
synthesis involving an “outside-in” approach.
Peripheral Functionality %  S  t  M
%  V - . ‘  v V .
^  2  Branching Units ^  ? # 4 0  t
I I J /
•  — - •
• >  V  > V '  •
^  "  ;  ?  *
*  \ \
| |  *
Core
DENDRON DENDRIMER
Figure [1.1]: Schematic diagram of the structure of a dendron and a dendrimer, 
highlighting the focal point or core (black) surrounded by rings of branching units 
(gray circles) and end-groups (rectangles).151
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1.1.2. Variations of dendrimer structure
In 2005, Frechet reported various designs o f  low polydispersity combinations o f  
dendrons and linear polymers 161 such as linear-dendritic hybrids,16'81 bow-tie 
dendrimers,19' 101 and dendronized polymers.16, 11131 Recently these new dendritic 
polymers have been applied in drug delivery and other biomedical applications.1141 In 
2009, El-Sayed and co-workers reviewed the field,1151 cataloging the dendrimer 
families which have been used as carriers in chemotherapeutic applications such as 
biodegradable ester dendrimers,116' 191 amino acid-based dendrimers,120'211 
glycodendrimers,1221 hydrophobic dendrimers,1231 in addition to other, less important 
types.
1.1.2.1. Asymmetric dendrimers
Although the symmetric architecture o f dendrimers has produced polymers with high 
monodispersity, new types o f  dendrimers based on an asymmetric architecture 
provides a series o f  novel structures which have interesting pharmacokinetic 
behaviour in vivo. Asymmetric dendrimers can be prepared by coupling different 
generations o f  dendrons onto a linear core, which produces a non-similar orthogonal 
dendrimer architecture. This asymmetry in the architecture provides exquisite control 
over the number o f  functional groups accessible on each dendron for loading o f  drugs 
in one dendron and targeting moieties, imaging agents, or other therapeutic moieties 
in the other. The “bow-tie” polyester dendrimers (Figure 1.2)l9 l0] are noted 
asymmetric dendrimers first synthesized by Frechet and co-workers. Lee and co­
workers also reported another class o f asymmetric dendrimers, using “click” 
chemistry to couple a propargyl G4 dendron to an azide functionalized G3 dendron, 
forming a triazole core.1241
2
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Figure [1.2]: represent "bow-tie" polyester dendrimer reported by Szoka and 
Frechet/101 The green dendron is functionalized with PEG arms (blue lines) to  
increase the dendrimer's solubility and in-vitro half life, whereas the other red 
dendron can be used for the loading of anticancer drug molecules (yellow ovals).1151
1.1.2.2. D ivergent s y n th e s i s  o f  PAMAM dendrim ers
As well as being the first dendrimers synthesised/ 251 poly(amidoamine) (PAMAM) 
dendrimers are also considered one o f  the best potential drug delivery carriers due to 
their high biocompatibility. They are: hydrophilic, nanostructured, mimics o f  globular 
proteins,[25] are transported across the epithelial barrier o f the gut/ 26'281 inhibit protein- 
protein binding,1291 and have intrinsically fluorescent behaviour under acidic 
conditions/ 301 in addition to their ability to load fluorescent compounds in their core 
and/or peripheries/ 31'391 The synthesis o f  PAMAM dendrimers is mainly dependant 
on iterative steps, initially Michael addition onto an alkyldiamine core (e.g., ethylene 
diamine; EDA) using methyl acrylate monomers to yield a branched intermediate, 
which can be converted to the smallest PAMAM dendrimer generations with N H2, 
COOH or OH terminal groups/ 401 Amidation is the second step, this smallest 
branched intermediate is reacted with excess EDA to produce GO with four NH2 
surface groups. Addition o f  methyl acrylate and then hydrolysis o f  the methyl ester
3
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COOMe group in this intermediate produces the smallest anionic dendrimer (G0.5) 
with four COOH groups.1401 Also, GO with four OH surface groups can be produced 
by replacing EDA with ethanolamine in the reaction with the smallest intermediate.1411 
Higher generations o f  PAMAM dendrimers can be synthesized by repeated Michael 
additions followed by amidation reactions (Figure 1.3).
NH
OMeNHNH NH
N —  N
NH-
(b) H,N NH-Core HN
HN
NH- NH;NH-
H2N
Generation 1
NH;
OMe
H2N NH-NH
NH;
NH;
NH;
NH-
^*^nh2
n h 2
G « 3-10
NH-
Figure [1.3]: Synthesis of tetra-functional poly(amidoamine) (PAMAM) dendrimers: 
exhaustive Michael addition of amino groups with methyl acrylate, followed by 
amidation of the resulting esters with ethylenediam ine.[25)
1.1.2.3. C onvergen t s y n th e s i s
Although convergent synthetic strategy pioneered by Hawker and Frechet overcame 
the problem o f  many divergent side-byproducts, relatively few methods are recorded 
to synthesise PAMAM dendrimer,[42] especially few in the solution phase143-481 where 
the use o f  different dendrons in solution needs large excesses o f  reagent which is 
impracticable. So Lee et al and co-workers (2006) presented the first synthesis o f
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poly(amidoamine) (PAMAM) dendrons in high yields by convergent synthesis1491 and 
by using click chem istry.1501 Furthermore, this method can afford PAMAM 
dendrimers possessing unsymmetrical branches with size-differentiation.t24]
1.1.2.4. M odification o f  pre-m ade PAMAM dendrim ers
A literature survey revealed many reports about synthetic modification o f  PAMAM
dendrimers at their core for use in biomedical applications,151'521 for example to 
conjugate an intercalating fluorescent chromophore as an antitumour compound 
(Figure 1.4).[531 Many recent papers are concerned with poly(amidoamine) dendrimers 
peripherally modified with 1,8-naphthalimide derivatives due to their strong 
fluorescence and good photostability[3,'3?1 Bojinov et al. used 1,8-naphthalimide 
derivatives to design novel PAMAM dendron functionalized at both core and 
peripherally with 1,8-naphthalimide fluorophores to provide a light harvesting 
antenna (Figure 1.5).[54]
Figure [1.4]: PAMAM dendritic polyam ines- Figure [1.5]: PAMAM dendron functionalized at 
(im ide-D N A  intercalator).1531 both core and peripherally with 1,8-
naphthalimide fluorophores. [54]
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1.1.3. Photophysical properties of PAMAM dendrimers
1.1.3.1. Intrinsically f lu o resce n t  behaviour
Poly(amido amine) (PAMAM) dendrimers with different terminal groups (NH2, OH, 
and COONa) show high fluorescence emission under different parameters and 
conditions. The fluorescent emission increases linearly with dendrimer concentration, 
or is rapidly increased by high temperature or at low pH, which may be attributed to 
the protonation o f  the tertiary amine groups (Figure l .6).t30,55]
Ex: G4-OH 
Ex: G4-NH2 
Ex: G4.5-carboxylate 
Em: G4-OH 
Em: G4-NH2
CO  Em: G4.5-carboxyl ate
£
C Vos
CO§
§  -9
jg <
o
3
250 300 350 400 450 500 550 600
Wavelength (nm)
Figure [1.6]: Fluorescence spectra of G4-OH, G4 -N H2, and G4.5-carboxylate at pH 6, 
the wavelength of excitation and emission was at 385 nm and 450 nm, respectively.
All solutions were 0.7 nM in w ater.[55]
1.1.3.2. PAMAM den d rim ers  con ju gated  with f lu o resce n t  c o m p o u n d s
Fluorescent compounds could be located at the focal point o f  PAMAM dendrons, at
the periphery or at both o f  these positions. For example, fluorophore compounds 
localized at the focal point o f a PAMAM dendron like a fullerene (fiillerodendron)[56' 
57] carbazole or pyrene moiety have been studied and demonstrate self-assembly 
behaviour.t58]
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Many recent papers have concerned PAMAM dendrimers peripherally modified with
1,8-naphthalimide derivatives due to their strong fluorescence.131"371 PAMAM 
dendrons o f  G 1-G3 generations have been modified with naphthyl groups at the 
periphery and a dansyl group at the focal point.1381 Other examples include the 
coupling o f  dansyl chloride, sulforhodamine B2 acid fluoride, coumarin-343, NBD 
chloride, and 5(6)-carboxyfluorescein pentafluorophenyl ester to dendritic PAMAM 
structures for use as new oligomeric fluorescent labelling compounds.1391
In 2008, Bojinov and co-workers localized 1,8-naphthalimide fluorophores at the core 
and periphery o f  PAMAM dendrons to for use as light harvesting antenna.t541
1.1.4. Biomedical Properties and Applications.
The unique features o f  dendrimer structures predispose them to be ideal nanocarriers 
for delivery o f  drugs and imaging agents into cells. The surface modification o f  
dendrimers can allow the loading o f  many functional molecules with specific 
properties to suit particular applications. In addition, attention is being paid to the 
potential use o f  dendrim er carriers to cross biological barriers, especially the blood- 
brain barrier (BBB) or gastrointestinal tract. It is expected that upcoming work in 
biomedical application o f  existing dendrimers will be also concerned with dendrimer 
toxicity and biocom patibility/59"601
1.1.4.1. PAMAM dendrimers as potential drug delivery carriers
The unique properties o f  PAMAM dendrimers are water solubility, nanosize and a
well defined macromolecule structured40, 61"621 The uniform expansion o f  size[621 
during generation increase make PAMAM dendrimers interesting mimics to globular 
proteins (Figure 1.7). There are many applications o f  PAMAM dendrimers in drug
7
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delivery,1[62] gene delivery,1641 and antisense oligonucleotide delivery.1651 Researchers 
still investigate and seek to understand the relationship between PAMAM dendrimer 
structural properties (size and charge)1271 and their ability to permeate cells that make 
up biological barriers.
 40 A—►
Cytochrome c
55A—►
Hemoglobin Prealbumin Hemerythrin
-30 A
Variable region 
surface area
(-20 k  30 A)
**---- 40 A
G = 4.0
67 A
G = 6.0G = 5.0 G = 7 0
Naked histone 
duster
Immunoglobulin
Lipid biiayer
24A
24/
DNA-histone
complex
Figure [1.7]: A dimensionally scaled comparison of a series of poly(amidoamine) 
(PAMAM) dendrimers (NH3 core; G = 4 -7 )  with a variety of proteins, a typical lipid- 
bilayer membrane and DNA, indicating the closely matched size and contours of 
important proteins and bioassemblies.[25]
1.1 .4 .2 . M ech a n ism s o f  drug load ing on to  dendrim er carriers
1.1.4.2.1. Physical encapsulation of drug molecules
Vogtle and co-workers investigated the trapping o f guest molecules into branched 
polymers1661 by physical encapsulation o f  insoluble drug molecules to improve their 
aqueous solubility and control their release profile (Figure 1.8).[3, ,6 67‘7()l Insertion o f  
hydrophobic molecules into dendrimers is usually achieved by mixing o f  drug
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solutions with the polymer, where the nonpolar core links with the hydrophobic drug 
by hydrophobic interactions.13,16,69'70]
1.1.4.2.2. Chemical conjugation o f drug molecules
On the other hand, different drugs, imaging agents, and/or targeting ligands can be 
covalently conjugated onto the periphery o f  dendrimers by direct coupling115,631 often 
using pH-or enzyme-sensitive linkages (Figure 1.9).*15,711
Figure [1.8]: Drawing of a dendrim er carrier encapsulating Figure [1.9]: Schematic drawing show ing a dendrimer-drug
hydrophobic drug m olecules in the dendrimer's voids to  conjugate w here th e  drug m olecules (red ovals) are either
increase their aqueous solubility and control their release directly coupled (solid line) to dendrimer's surface groups
rate.1151 or via a pH- sensitive linkage(blue rectangle).111
1.1 .4 .3 . D endrim ers a s  im aging a g e n ts
One o f  the first uses o f  dendrimers in vivo was as carriers for magnetic resonance 
imaging contrast reagents*72'731 Another imaging application involves photonic oxygen 
sensing*741. Dendrimers with solubilizing and steric-stabilizing core-shell architecture 
have been developed for new photophysical technology, and offers promise for 
accurate, noninvasive optical imaging.*751
1.1 .4 .4 . P h arm a co k in etics
Investigation o f  dendrimer pharmacokinetics parameter are now essential for any 
further biomedical applications, because toxicity and bioavailability o f  any drug or
9
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imaging agent loading to dendrimers will depend on their release rates from 
dendrimers and elimination rates.t?6]
1.2. Dendrimers containing Fluorescent Labels.
Recent literature surveys indicate continuing interest in water soluble fluorescent 
dendrimers for visualisation and diagnostic imaging applications.[75, 77-81] As most 
fluorophores are quenched in aqueous media due to aggregation o f  the hydrophobic 
fluorophore, the concept is to use the bulky water-soluble dendritic structure to protect 
the fluorophore and hinder self-association.[8l] Essentially, the location o f  the 
fluorophore(s) has played an important role in both controlling the synthesis o f  the 
dendrimer and its properties. The fluorescence o f  water-soluble dendritic compounds 
can be due to the entire macromolecular structure, or discrete fluorophores could be 
used as peripheral groups, as branch points or as the core. As a result, there are many 
types o f  water soluble fluorescent dendrimers, such as intrinsically fluorescent 
dendrimers, multiply labelled dendritic structures, statistically labelled dendritic 
structures, or dendrimers with fluorescent cores (Figure 1.10)J8I]
i r
&:  fluorescent group
^ : charged and/or 
^  water-solubilizing group
B  Q  : biologically active groups jTV-
Figure [1.10]: Schematic representation of type of fluorescent dendrimers.[81]
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1.2.1. Type
1.2.1.1. Intrinsically fluorescent dendrimers
Until recently, there were no reports o f  fluorescent PAMAM dendrimers.[821 This is 
due to its structure lacking any classical fluorophores but after more than 15 years 
from their first disclosure, the fluorescent properties o f  -CO O H  terminated PAMAM 
were investigated and were attributed to n-7t* transition o f  amido groups.[83J Also blue 
fluorescent emission was noticed due to the oxidation o f  NH2- or OH -terminal 
groups1841 and a well-defined dependancy o f  the fluorescence with the pH especially 
in acidic media,155’851 Recently, all poly(propyleneimine) (PPI),[3°5 poly(propyl ether 
imine) (PETIM) dendrim ers,[ 861 and polylysine NH2-terminated dendrimers were also 
revealed to be intrinsically fluorescent.[87]
1.2.1.2. Multiply labelled dendritic structures
Most fluorescent labelled compounds are water-insoluble due to the presence o f 
aromatic groups in their structure, so the solubility o f  fluorescently-labelled 
dendrimers decreases as the number o f  fluorescent aromatic compounds increase. 
There are two main ways to overcome these disadvantages. The first is to use water- 
soluble compounds as an inner part o f  the dendrimer, or by using water soluble 
compounds as terminal groups in addition to fluorescent compounds.1811
Many types o f  1,8-naphthalimide derivatives have been conjugated to PAMAM 
dendrimers as terminal groups to provide cationic sensors in polar solvents except 
water (Figure 1.11 ).f321 In addition, dansyl, naphthyl, or pyrenyl fluorescent terminal 
groups were loaded onto PAMAM dendrimers o f 0-5 generations but studies indicate 
strong aggregation behaviour in w ater.f881
11
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Figure [1.11]: 4-Ethylam ino-l,8-naphthalim ide-labeled PAMAM
dendrimers. [32]
Another strategy to achieve a combination o f  water-solubility and fluorescence is to 
have two dissimilar kinds o f  terminal groups, one for water solubility and one for 
fluorescence. This approach can be achieved in two ways: the first by grafting the two 
types o f  groups onto two distinct areas o f the dendritic periphery (so-called “Janus”- 
type dendrim ers),[89] and the second by linking both monomers simultaneously to each 
terminal branching point. Another approach consists o f  having the two different types 
o f functional groups linked to the branching points, leading to “multi-pluri- 
functionalised” compounds.[90] In the case o f  water-soluble fluorescent dendrimers, 
this approach was primary applied to ammonium groups and dansyl derivatives.[9,]
12
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1.2.1.3. Statistically labelled dendritic structures
In biological trials on water soluble dendrimers; especially PAMAM dendrimers, the 
statistical conjugation o f  a few fluorophores as terminal groups has gained 
prominence. For example, fluoresceine isothiocyanate (FITC) and Oregon Green 488 
(OG488; Figure 1.12) fluorophores two closely related compounds have been 
incorporated by statistical couplings on the terminal groups o f  dendrimers.[811 These
conjugated fluorophores do not appear to alter the biological activity or transport o f 
the dendrimers.[92'931
Figure [1.12]: Types of fluorophores linked statistically (one to a few) to the surface
of dendrim ers.1811
Recently, this concept o f  statistical conjugating has been used as a multifunctional 
platform by introducing up to five different terminal groups on the dendritic structure. 
In most cases these types o f  compounds were synthesised from PAMAM dendrimers 
(except one example based on PPI dendrimers^941) for various biological applications, 
like imaging and tum our treatment.t811 However, the statistical loading o f  fluorophores 
into the periphery o f  dendrimers has problems, like fluorescent quenching, in addition 
to the difficulties o f  controlling stoichiometry,[95%1 and the possibilities o f  changing 
biological function or transport.1971 These potential disadvantages can be addressed by 
loading the fluorophore into the core o f  dendron.
COOH CO O H
.0
OG  488 FITC
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1.2.1.4. Dendrimers with fluorescent cores
Phthalocyanines and porphyrin fluorophores have been used as a fluorescent core in 
many known families o f  dendrimers. It is assumed that the dendrons protect the 
fluorescent core from any outer environmental effects^981 in particular by preventing 
aggregation and protecting it against quenching by water, but by using appropriate 
terminal groups, solubility in water is induced. The first examples o f  water-soluble 
porphyrins embedded in a dendrimer (Figure 1.13) were synthesised with the aim o f  
providing synthetic models o f  natural enzymes, such as cytochrome-c.[99J Dendritic 
water-soluble phthalocyanines have closely related structures and properties to 
dendritic porphyrins.[ 100 1061 Besides porphyrins and phthalocyanines, stilbene 
derivatives have also been used as fluorophores that can be used as the core o f  water- 
soluble dendrimers.fl07’112J
C00R3 / 
R3°°C \  '
COORj
RjOOC^
RjOOC—^ 9
.0
RjOOC,
NH
\—O
RjOOC x  / — 1— N 
O J  H
RjOOC^
(Gd
R. ° ° S r ,OOC
n O /COOR3
' Qy  j :oor,
HN P ^--COOR,
O COORj
NH
O
COORg
'0 ^ ,C O O R j
(a): M = Zn; R1 = H; R2 = R3 = H
(b): M = FeCI; R1 = H; R2 = R3 = o
4a-f-Gn
Figure [1.13]: Types o f  water-solubilising branches linked to a porphyrin core.
1.2.1.5. Dendritic wedges with fluorescent ‘cores’.
In this case, the attached dendrons cannot fully protect the fluorophores against any 
environmental effects and aggregation, however, dendrons may be used simply to 
increase the solubility o f  the ‘core’ (or more correctly focal-point) unit in water, for
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example, C(,q fullerene,1113' 1151 which is insoluble in aqueous and most polar media. A 
different kind o f water soluble fullerene dendron was constructed using PAMAM 
dendrons. Due to the protonation o f nitrogen in the internal structure, such compounds 
are water soluble in acidic conditions, even with methyl ester terminal groups (Figure 
1.14).157, 1,61 Other strongly fluorescent probes have been place at the core o f  
PAMAM dendritic wedges including: py rene/117' 1201 carbazole fluorophores1581 and 
dansyl fluorophores.1121' 1221
MeOO'
> NH
CO OMe
O^/NH OOMe
NH
COOMe
, 0 0 0  Me
12-G2
NH
\
COOMe
N'
'COOMe 
MeOOC
Figure [1.14]: Water soluble fullerodendron.
1.2.2. Applications of fluorescent dendrimers
Fluorescent dendrimers can be used for biological imaging. O f particular importance 
is their use in conjuction with novel one-photon[1231 and two-photont124' 1251 fluorescent 
tumor-sensing systems that have been developed to provide high spatial (//M) 
resolution. For example, the two-photon optical fluorescence fibers technique together 
with a G5-PAM AM  dendrimer conjugated to folic acid and the fluorescent probe 6- 
carboxytetramethylrhodamine succinic ester (6-TAMRA) has been used to image 
tumors in-vivo.[ 1261281 Florescent dansyl units have also been incorporated into
15
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dendrimers and their cellular uptake and localization studied using confocal 
fluorescence microscopy.*1291
1.3. Fluorescent Compounds
1.3.1. Principles of fluorescence spectroscopy
1.3.1.1. Fluorescence
All molecules have internal energy levels, in which an electron can transfer from the 
lower to higher level when the molecule absorbs a photon o f  light o f  equal energy to 
the energy difference between two energy level states (Figure 1.15).*1303
eieuirumu yruunu state
Figure [1.15]: Jablonski diagram of organic dyes: 1C—internal conversion, ESA- 
excited state absorption, ISC—intersystem crossing.*1313
The fluorescence process involves instant emission o f  electromagnetic energy from 
the singlet state, while the related phosphorescence process occurs when the energy 
emission originates from an excited triplet state and is delayed relative to the 
fluorescence emission.*1303
s
excited vibrational states 
(excited rotational states not shown)
n
S -  singlet si 
T = triplet sU 
1C = internal 
ISC -  intersy
A -  photon absorption
F = fluorescence (emission)
P = phosphorescence
tate
tate
conversion
rsystem crossing
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1.3.1.2. Structural factors that determine fluorescence
Generally, strongly fluorescent molecules possess the ability to easily transfer
between two transitional energy states via a small energy gap. Usually, aromatic 
compounds possess very strong fluorescence due to two reasons: the first is the 
presence o f  71- electrons system in which electrons are more easily transferred to 
higher 7 1 *  antibonding orbitals by light absorbance without affecting bonding. The 
second reason is the allowance o f  7 t-7 t*  transition singlet states that are often involved 
in very strong fluorescence.11305 Fluorescence in an aliphatic compound is often 
insignificant except for carbonyl-containing compounds that can show signs o f  weak 
fluorescence due to n-7c*transitions.[l30] Rigid co-planarity is also a prerequisite for 
strong fluorescence as it favours n- 7t* transitions singlet states. For example, (Figure 
1.16) shows fluorescein which possesses rigid planarity so it strongly fluoresces, 
while phenolphthalein does not and has greater rotational freedom and dissipates its 
energy in solution.l '30^
O
COO
Phenolphthalein
O
COO
Fluorescein
Figure [1.16]
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1.3.2. PAMAM conjugation to naphthalic anhydride derivatives
1.3.2.1. Synthesis and Photoluminescence properties
There are many references concerned with the synthesis o f  N-aryl- naphthalimide 
derivatives1132' 1371 (Scheme 1.1) and N-alkyl-naphthalimide derivatives (Scheme
j 2 )  [138-145]
COOH
CHgCOOH / CH3COONa 
or
CHgCOOH / (CH3COO)2Zn 
or
DMF
COOH
Reflux
O-^ /NL / O
Scheme [1.1]: Example for synthesis of N-aryl-naphthalimide derivatives
NH.
. cl .O O- L
,NH.
EtOH or H20
CK
heating
Scheme [1.2]: Example for synthesis of N-alkyl-naphthalimide derivatives 
Because o f  their strong fluorescence and good photostability, the 1,8-naphthalimide
derivatives have found application in a number o f  areas including colouration o f
polymers,11461501 laser active m ed ia /151' 1521 photosensitive biological units,11531 
fluorescent markers in b io logy /1541 analgesics in m edicine/1551 light emitting 
d io d es/156' 1581 photo-induced electron transfer senso rs/159' 1631 fluorescence 
sw itchers/164' 1661 and ion p ro b es /1671 Also, some A-alkyl-1,8-naphthalimide
derivatives have been characterised by Lewis et al. as photo-chemotherapeutic
inh ib ito rs/168' 1721
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The colour o f  1,8-naphthalimide derivatives usually depends on the presence and type 
o f  substituent at the 4-position o f the naphthalimide ring. For example, electron- 
donating amino groups1163,173 ,761 cause a red-shift in the visible adsorption band with 
an increase in the quantum yield o f  fluorescence. It has been concluded that the 
fluorescent character o f  1,8-naphthalimides also depends on the polarisation o f  the 
naphthalimide molecule due to the electron-acceptor donor interaction occurring 
between the carbonyl groups and the C-4 substituents o f  the chromophoric system 
(Figure 1.17).‘I77-|78J
Figure [1.17]: intramolecular charge-transfer analogue of 4-am ino-l/8-naphthalimide
derivatives.11771
1.3.2.2. PAMAM conjugates
1.8-Naphthalimide 6 and the dendronized dyes 7 and 8 (Figure 1.18), represent good 
model structures for the concept o f  “fluorophore-spacer-receptor” where the 4-amino-
1.8-naphthalimide moiety is the fluorophore and the terminal ester or amino dendrons 
are the proton receptors, while the ethylenediamine spacer separates the fluorophore 
and dendron unit. The fluorescence emission o f  the 1,8-naphthalimide unit is 
quenched by the PET process (an electron transfer from the amine receptor to the 
excited state o f  the fluorophore), which represent the “off-state” o f  the system.
19
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£
MeO
MeO-
H2N
Figure [1.18]: compound structures 5, 6, 7 and 8.
In acidic solution, fluorescence emission o f  the compounds is “switched on” due to 
the protonation o f  the amine receptor (Figure 1.19).[174, l79 180] The fluorescence 
quantum yields o f  compound 5 is higher than compounds 6 -8  due to the absence o f  
PET process which quenches the fluorescence emission.1181 183]
energy and electron transfer energy and electron transfer
V Q , OMe V Q ■FV > “ 1■uryty* ry > > N
FI.
y ~OMe
o fiu
V-OMe
O
Fluorophre Spacer Receptor
♦
Fluorophre Spacer Receptor
H
[ s w itc h e d  off] [ s w itc h e d  o n ]
Figure [1.19]: "Fluorophore-spacer-receptor" model with indicating "off -  on" 
switcher for PET process in prescent and absence of acidic media
Bojinov and co-workers used 1,8-naphthalimide derivatives to design, a novel 
PAMAM dendron 9, which was substituted at both core and periphery with 1,8- 
naphthalimide fluorophores. In this new-light harvesting antenna compound 9, the
20
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periphery is functionalized with “donor” dyes (blue emitting 1,8-naphthalimides) 
which absorbing the light and transfer the energy to a single “acceptor” dye (yellow- 
green emitting 1,8-naphthalimide) at the focal point o f  the dendron (Figure 1.20).[54]
4 3 0  nm
NH5 1 0  nm 3 6 0  nm
3 6 0  nmNH
4 3 0  nm
Figure [1.20]: Compound 9 . [54]
1.3.2.3 Chemotherapeutic applications
In the literature, there are several examples o f  naphthalimide derivatives as DNA 
intercalating agents and anticancer agents.[184-1881 Two important prototypes o f  the 
series are Mitonafide and Amonafide (Figure 1.21) which, although characterized by a 
valuable anticancer profile, did not pass the phase II because o f  their toxicity.1189-1901
M ito n a f id e  A m o n a f id e
Figure [1.21]: Chemical structures of compound Mitonafide and Amonafide.
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Therefore, PAMAM and PPI dendritic wedges, containing an intercalating 1,8- 
naphthalimide derivative at their core, have been employed in gene therapy and act as 
an antitumour agent (Figure 1.22).[l4,]
Figure [1.22]: Compound A: "PPI dendritic polyamines-(imide-DNA intercalator)" 
conjugates, Compound B: "PAMAM dendritic polyamines-(imide-DNA
intercalator)".11415
As noted above, recent literature indicates continuing interest in water-soluble 
fluorescent dendrimers for biological applications including visualisation and 
diagnostic imaging. It is clear that the loading o f  fluorophores onto the periphery o f  
dendrimers is still not trivial, with difficulties o f  stoichiometric control for 
synthesis195'961 and issues in the performance o f  the resulting conjugates such as 
fluorescent quenching. These disadvantages may be avoided by loading the 
fluorophore into the core (or focal point) o f  a dendron.
C o m p o u n d  B C o m p o u n d  A
1.4. Aim of Project
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As well as being the first high-generation dendrimers and one o f the most studied,t25] 
poly(amidoamine) (PAMAM) dendrimers are also considered one o f  the best potential 
drug delivery carriers due to their high biocompatibility. They are: hydrophilic, 
nano structured, mimic globular proteins,[25] readily transported across the epithelial 
barrier o f  the gut,[26'28] and inhibit protein-protein binding.[29] As potential 
fluorophores, 1,8-naphthalimide derivatives are attractive as they possess strong 
fluorescence and good photostability which makes then useful as fluorescent markers 
in biology,[l54] and as intercalating and anticancer agents.[l84' 1881
The objective o f  this research project was the synthesis and study (photophysical and 
physicochemical) o f  novel fluorescent PAMAM dendritic molecules containing 1,8- 
naphthalimide or one o f  its simple derivatives at the core. The project was divided 
into three consecutive stages, the first stage encompassed the chemical synthesis and 
photophysical studies o f  some 1,8-naphthalimide derivatives to investigate the 
fluorescent behaviour o f  these compounds. In the second stage, novel fluorescent 
PAMAM dendritic molecules were to be prepared with the optimised core selected 
from the initial work. Finally, in collaboration with other research groups the 
physicochemical properties, their transport through biological barriers and their 
binding to DNA was to be assessed.
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2.1. Synthesis
2.1.1 Synthesis of N-alkyl-1,8-Naphthalic anhydride derivatives
The routes to the synthesis o f  /V-alkylamino- 1,8-naphthalimide derivatives CF1-CF3 
are presented in (Schemes 2.1-2.3). Compound CF1 was prepared according to a 
published procedure.11431
h 2n '
.NH,
QE1
Scheme [2.1]: Synthesis of CF1. Reagents and conditions: EtOH, Reflux 8 h.[143]
Also by the analogue previous published procedure,11431 the reaction o f  1,8-naphthalic 
anhydride 1 with 1,2-propanediamine in boiling ethanol gave the desired CF2 (Scheme 
2 .2 ).
h 2n
NH,
53%
CF2
Scheme [2.2]: Synthesis of CF2. Reagents and conditions: EtOH, Reflux 8 h.
Compound CF3 (Scheme 2.3) was obtained using a similar procedure utilising a Boc- 
terminated diamine (designated BocNH) which was prepared as previously 
report ed.[ 1911 The Boc-group was removed by treatment with TFA/DCM according to 
a standard procedure^ 1921 to give CF3 as a new compound.
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1 BocNH
98%
CF3
Scheme [2.3]: Synthesis of CF3-Boc and CF3. Reagents and conditions: (i) EtOH, 80
°C, 1 h; (ii) TFA/DCM, stirring 2 h.
2.1.2 N-aryl-1,8-Naphthalic anhydride derivatives.
Precursor compounds 3,6-dinitro-l,8-naphthalic anhydride 2 and 3,6-diam ino-1,8- 
naphthalic anhydride 3 were prepared according to published procedures11931 (Scheme 
2.4).
o
ODnc. q S 0 4 + HN03 W /G  q
NCt,
DMF, RT
Nq
1
Scheme [2.4]: Reported synthesis of 2 and 3. Reagents and conditions: (i) Cone. 
H 2SO4/HNO3; (ii) DMF, Pd/C 10%, H2, stirring 16 h, RT.
//-phenyl-1,8-naphthalimide derivatives A l, A2 and A4 were synthesized by refluxing
1,8-naphthalic anhydride derivatives 1, 2 and 4 with 4-aminobenzoic acid in the 
presence o f  glacial acetic acid and sodium acetate. A l, A2 and A4 were all obtained in 
good yield with high purity without any need for further purification (Scheme 2.5).
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R
R
1 2 , 4
+  H„N CO O H COO H
R '
R
1 M R= H,
zIIhe. A l = 92%
r = n o 2, R'= H A2 = 93%
fL M R= H, R'= Br M  = 68%
Scheme [2.5]: Synthesis of A l, A2 and A4. Reagents and conditions: AcOH/AcONa,
Reflux.
Compounds B l, B2, and B4 were obtained using the same procedure by replacing 4- 
aminobenzoic acid with 5-aminoisophthalic acid (Scheme 2.6).
R'
R
C O O H
CO O H
CO O H
R'
COO H
R
L L ± L S I R= H, R'= H
2, B2 R= N 02, R -  H
4, B4 73 II Z R’= Br
B1 = 92% 
B2 = 95% 
B4 = 85%
Scheme [2.6]: Synthesis of Bl, B2 and B4. Reagents and conditions: AcOH/AcONa,
Reflux.
Compounds Cl, C2 and C4 have been prepared by the same procedures as above 
(Scheme 2.7), however, their yields were much lower due to the formation o f  
byproducts. Purification was achieved using flash column chromatography (CHCI3 : 
MeOH : N H3; 9 : 1 :  0.1).
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R
1 2 ,4
C O O H
1 M R= H, R'= H
2, A2 r = n o 2, R -  H
1 M R= H, R'= Br
COO H
R '
R
M  = 92% 
M  = 93% 
M  = 68%
Scheme [2.5]: Synthesis of A l, A2 and A4. Reagents and conditions: AcOH/AcONa,
Reflux.
Compounds Bl, B2, and B4 were obtained using the same procedure by replacing 4- 
aminobenzoic acid with 5-aminoisophthalic acid (Scheme 2.6).
R'
R
C O O H
+ h2n ^
C O O H
1 2 ,4
COO H
R'
COO H
R
I M
z11z z11£
2, B2 R= N 02, R'= H
4, B4 R= H, R -  Br
B1 = 92% 
B2 = 95% 
B4 = 85%
Scheme [2.6]: Synthesis of Bl, B2 and B4. Reagents and conditions: AcOH/AcONa,
Reflux.
Compounds Cl, C2 and C4 have been prepared by the same procedures as above 
(Scheme 2.7), however, their yields were much lower due to the formation o f 
byproducts. Purification was achieved using flash column chromatography (CHCI3 : 
MeOH : NH3; 9 : 1 :  0.1).
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R'
R
C O O H
+  h 2n — ^  ^
NH.
1 2 ,4
C O O H
R'
n h 2
R
1 £ L R= H, R'= H
2, £ 2 R = n o 2> R'= H
4, £ 4 R= H, R'= Br
£1= 43%  
£ 2 = 12% 
£ 4  = 11%
Scheme [2.7]: Synthesis of Cl, C2 and C4. Reagents and conditions: AcOH/AcONa,
Reflux.
The byproducts o f  the previous reaction were found to be C ll, C22 and C44, however, 
these are all desirable and so were prepared using the same procedure but using 
double the amount o f  anhydride over an increased period o f  time. Separation was also 
achieved using flash chromatography (CHCI3 : MeOH : NH 3 ; 9 : 1 : 0.1) (Scheme 
2 .8 ).
C O O H
R'
R ’
1 2 ,4
COO H
+
n h 2h 2n
£11= 75%R=H, R'= H 
R = N 02, R’=H 
R'= Br
£ 2 2 =  71%
£4 4  = 67%4 ,0 4 4 R= H
Scheme [2.8]: Synthesis of C ll, C22 and C44. Reagents and conditions: AcOH/AcONa,
Reflux.
The 3,6-diamino- 1,8-naphthalimide derivatives A3, B3, C3 and C33 were prepared 
according to an analogous reported procedure,[ 1921 with slight modifications, for the 
hydrogenation o f  the nitro groups using Pd/C 10% in DMF solution (Scheme 2.9).
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■COOH
0 ?N
h 2n
COOH
h 2n
0 2N
COOH
COOH
o 2n B2
h 2n
COOH
COOH
h2n 51
Scheme [2.9]: Synthesis of A3 and B3. Reagents and conditions: DMF, Pd/C 10%, H2,
stirring 16 h, RT.
The reaction was monitored by TLC and once complete the catalyst was filtered o ff 
and the filtrate poured into DCM (250 mL). The solid precipitate was then easily 
collected by filtration.
Compounds C3 and C33 were prepared by the same procedure over 24 hours, the final 
products were purified by flash chromatography (CHCI3 : MeOH : AcOH; 8 : 2 :  0.5) 
(Scheme 2.10).
h 2n
n h 2
COOH
h 2n
n h 2
COOH
0 2N
Q2 £ 3
OOH OOH
h 2n .n o 2
n h 2
89%
C 22 n o 2 n h 2
Scheme [2.10]: Synthesis of C3 and C33. Reagents and conditions: DMF, Pd/C 10%,
H2, stirring 24 h, RT.
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2.2 Photophysical studies
2.2.1 UV-vis absorption spectra
As reported, precursor 1 has its longest wavelength UV-vis adsorption band Xmax at 
330 nm; 2 at X m a x = 277 due to the two nitro withdrawing groups in positions C-3 and 
C-6; 3 at Xmax = 439 nm due to presence o f  two amino electron-donating groups in 
positions C-3 and C-6 ; 4 at Xmax = 340 nm with the slight red-shift due to the bromine 
atom at position C-4. As expected due to the similarities o f  their basic chromophore, 
the derivatives o f  N -ary l-l,8-Naphthalic anhydride derivatives A1-A4 (Figure 2.1), 
B1-B4 (Figure 2.2), C1-C4 (Figure 2.3) and C11-C44 (Figure 2.4) have similar spectra 
to those o f  compounds 1-4. The N-alkyleamino- and imidazole-based naphthalimide 
derivatives CF1-CF3 (Figure 2.5) have Xmax at 340 nm.
A1 
A2
A4
0.6
Figure [2.1]: UV absorbance spectra for compounds A l- Figure [2.2]: UV absorbance spectra for compounds 
A4 in DMF solvent. B1-B4 in DMF solvent.
29
Chapter Two: Fluorescent Cores
 Cl
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W avatongth (nm)
42 0 4 7 0340 4 9 0
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Figure [2.4]: UV absorbance spectra forFigure [2.3]: UV absorbance spectra for
compounds C1-C4 in DMF solvent compounds C11-C44 in DMF solvent.
0.9
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0.7 H
0.6  -  CF1
—  CF2 
 CF3
0.5 j
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300 320 340
Wavelength (nm)
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Figure [2.5]: UV absorbance spectra for compounds 1, CF1-CF3 in DMF solvent.
2.2.2 Relative fluorescence intensity (RFI)
All the compounds prepared for this study were soluble in DMF and the relative 
fluorescence intensity (RFI) was recorded at constant UV absorbance o f  0.7 (Table 
2 . 1).
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Table [2.1]: Summary of fluorescent wavelengths and relative fluorescence emission 
intensity placed in order of increasing fluorescence intensity.
Compound Wavelength (nm) Fluorescence emission intensity
C22 342 16.19 x 10'3
C1 422 20.20 x 10'3
C4 428 26.50 x 10'3
2 411 27.19 x 10'3
A1 383 27.30 x 10 3
C44 401 27.86 x 10'3
A4 402 29.36 x 10‘3
C11 405 32.60 x 10'3
C2 455 35.80 x 10'3
CF1 425 35.84 x 10‘3
1 380 39.85 x 10'3
A2 341 58.78 x 10‘3
B1 410 71.08 x 10'3
4 455 79.26 x 10'3
B4 408 90.60 x 10'3
CF3 383 97.70 x 10'3
B2 419 1409.4 x 10’3
A3 518 3164.5 x 10‘3
B3 518 3434.9 x 10‘3
C3 521 4785.8 x 10‘3
3 518 6213.1 x 10‘3
C33 518 6489.4 x 10’3
CF2 432 148310.0 x 10'3
As was expected, the RFI order o f  TV-aryl am ino-1,8-naphthalimide derivatives mainly 
depends on the intramolecular charge-transfer in the delocalized structures (Figure 
2.8). This in turn depends on the type o f  functional groups present at the C-3 and C-6 
positions (H, NO2 or NH2), or the functional group on C-4 (e.g. Br) (Figure 2.6). The
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RFI can be summarized by placing the following in ascending order NO2 < H < Br 
« <  NH2.
O. .O
Br
H2N n h 2
III IV
Figure [2.6]: Order of Relative fluorescent intensity of /V-arylamino-l,8-naphthalimide
derivatives
With regards to N -alkylam ino-l,8-naphthalimide derivatives (Figure 2.7), their RFI 
mainly depends on the “fluorophore-spacer-receptor” model and Photoinduced 
Internal Electron Transfer (PIET) process.[I8I I83J
/  \
- 0  0 -
CF3
-NH ,
Figure [2.7]: Order of Relative fluorescent intensity of /V-alkylamino-1,8-
naphthalimide derivatives
The RFI o f  compound CF1 is very low and close to that o f  compound 1 due to PET 
processes which quench the fluorescence o f  the anhydride moiety (Figure 2.8).
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energy and electron transfer
Fluorophore Spacer Receptor
CF1
Figure [2.8]: (a) Conjugation process of compound 1, (b) Fluorescent quenching 
process result from PET for compound CF1.
Compound CF3 has a fluorescence intensity three times larger than that o f  CF1 
although it could potentially also suffer from a similar PET process as for CF1. A 
possible explanation for this is the length o f  the spacer in CF3, which is three times 
longer than in FC1. As a result, the possibility o f  CF3 undergoing a PET process is less 
than the probability for CF1 (Figure 2.8).11941
Compound CF2 (Scheme 2.2) possesses the highest RFI value, especially when 
compared to V-alkylamino and V-arylam ino-l,8-naphthalimide derivatives. This high 
intensity o f  fluorescence might be interpreted according to two factors: firstly, there is 
no possibility for PET process, secondly, the nitrogen atom o f  the imidazole ring 
participates in the resonance conjugated anhydride system with a push-pull interaction 
via the n system. (Figure 2.9) shows the difference between the fluorescence o f  
solutions o f  CF1 and CF2 under short-wavelength UV illumination.
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Figure [2.9]: Blue-green emitting for compounds CF1 and CF2 under short UV region.
The high fluorescence o f  compounds A3, B3, C3, 3, C33 (Figure 2.10) might be 
interpreted according to two points: firstly, there is no potential for PET, and 
secondly, the presence o f  the two amines (positions C-3 and C-6), which can interact 
with the imide ring via conjugation through the n system. [l95' 197]
700
<u ^  
V  Q>
600
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Z  8 400
U c/)
g  £  300
</> <Qj - £ 200O 3
u. 100
•C33
•3
■C3
*B3
•A3
350 450 550 650
Wavelength (nm)
750
Figure [2.10]: Relative fluorescence emission spectra of compounds 3, A3, B3, C3, 
and C33, when excited at wavelength \ max 439 nm.
Figure (2.11) shows the difference between the fluorescence o f  solutions o f  3, A3, B3,
C3, and C33 under short-wavelength UV illumination.
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Figure [2.11]: Green emission for compounds 3, A3, B3, C3, C33 under short UV
region.
2.2.2 Fluorescence quantum yield (OF)
The target compounds were designed as potential fluorescent cores for dendritic 
molecules with amino and carboxylic acid groups that can be functionalised. Hence, 
the fluorescence quantum yields Of, for the compounds possessing high RFI 
emission, were measured (Figure 2.12).
^  0 .7  -r
Li_
& 0.6
2
a)
>  0 .5  
E
|  0 .4  
to
§■ 0.3  
8
5 0.2 +
5 0.1 3
0.63454
0.22939
0.16657  0 .17289
0.07387
0.10342
A3 B3 C3 C33 CF2
Figure [2.12]: Fluorescence quantum yield for compounds A3, B3, 3, C3, C33 and 
CF2, when excited at wavelength Xmax 439 nm.
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2.3. Conclusions
Based upon these photophysical measurements it was 
modifiable derivatives o f  CF2 as the fluorescent core 
fluorescent dendrons for pharmacological use.
decided to use readily 
in the design o f  highly
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C hapter Three: Fluorescent PAMAM Carriers
Recently, water-soluble fluorescent dendrimers have become an increasingly important 
class o f  labelling reagent for biological applications. Fluorescent labelling reagents are 
required to have high sensitivity, appropriate excitation and emission maxima, and 
specific functionality. Therefore, it is important to design and develop new fluorescent 
labelling reagents, which have high detection limits and appropriate fluorescent 
behaviour.fl98]
3.1. Design and synthesis
Herein we report work on PAMAM dendritic wedges (i.e. dendrons) with a fluorescent 
label at their focal point or, to retain conventional dendrimer terminology, their ‘core’. 
Based on the work in the preceding chapter, it was decided to design the dendrons on the 
highly fluorescent unit FC2 because o f its chemical stability and its strong 
fluorescence.1198'204] It should be noted that many similar derivatives o f 1,8-naphthalic 
anhydride have been developed as fluorescent dyes and whitening agents,[205'206] but these 
suffer from being insoluble in aqueous and most polar media. So for our target materials 
the PAMAM dendron is used to enhance their solubility in water and, hopefully, their 
biocompatibility.
3.1.1 Synthesis of fluorophore core (FC2 GO).
The synthesis o f  3-(2-aminoethylamino)-7H-benz[de]benzimidazo[2,l-a]isoquinoline-7- 
one FC2G0 (Scheme 3.1) was achieved by the reaction between o-phenylenediamine 10 
and 4-bromo-l,8-naphthalenedicarboxylic anhydride 4 to give isomers FC2 (3-bromo) and 
FC2* (4-bromo), which were carefully separated by column chromatography.[ 1985 FC2 
reacted with ethylenediamine by two different methods (A, B) to afford the corresponding 
substitution product FC2G0 in low but sufficient yield.
37
Chapter Three: Fluorescent PAMAM Carriers
XL
N H ,
54%
NH2
FC2 GOFC2
Method (A) 14%
Method (B) 19%
FC2*
Scheme [3.1]: Synthesis of FC2 and FC2G0. Reagents and conditions: (i) AcOH, reflux 2 h; 
method (A) MeCN, EDA, reflux 3 days; method (B) EDA, heating 130 °C for 1 h.
Although there is significant literature about the synthesis, characterisation and potential 
applications o f  FC2 and FC2G0 or their derivatives, some o f  these references did not refer 
to the separation o f  the two isomers FC2 and FC2*,[200 ’207'213^ whereas others discuss this 
in some detail due to the ultimate application o f  the compounds or their derivatives.^198’199, 
204] We found it convenient to react a mixture o f  FC2 and FC2* with ethylene diamine (a 
nucleophilic aromatic substitution) and then separate the products by preparative HPLC as 
shown in (Scheme 3.1). (Figures 3.1-3.4) indicate the purity o f  the resulting product 
FC2G0 and ester PAMAM dendrons FC2G0.5, FC2G1.5, FC2G2.5, respectively.
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Figure [3.1]: Prep. HPLC Curve for FC2 GO (10.533 min.)
Figure [3.2]: Analytical HPLC Curve for FC2 G0.5 (7.118 min).
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Figure [3.3]: Prep. HPLC Curve for FC2 G1.5 (11.650 min.)
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Figure [3.4]: Prep. HPLC Curve for FC2 G2.5 (10.633 min.)
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3.1.2. Synthesis of fluorescent PAMAM dendritic wedges 
FC2G0.5 -  FC2G2.5 ( COOMe, NH2).
To overcome the necessity for protection, it was decided to initiate a PAMAM synthesis 
from FC2G0 (Scheme 3.2). The lone pairs on aromatic nitrogens are partially delocalised 
within the aromatic ring, resulting in a much reduced nucleophilicity when compared to 
the aliphatic nitrogen whose lone pair is free to react under the Michael conditions 
employed during PAMAM synthesis.[2l4] This means that the reaction between FC2 and 
ethylenediamine addition occurs specifically on the aliphatic nitrogen, rather than the 
aromatic nitrogen. FC2G0 was then further reacted with methyl acrylate by Michael 
addition12151 to yield FC2G0.5, followed by amidation with ethylenediamine to yield 
FC2G1. Repeating Michael additions and amidations resulted in dendrons o f  higher 
generations, FC2G1.5 through FC2G2.5 (Schemes 3.3, 3.4 and 3.5).
FC2 GO
77%
57%
O NHL
0  NH2
FC2 GQ.5 FC2Q1
Schem e [3.2]: Synthesis of FC2G0.5 and FC2G1. Reagents and conditions: (i) Methyl 
acrylate, MeOH, reflux 6 h, stirring 16 h, r.t; (ii) MeOH/DCM, EDA, stirring 2 days/N2.
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For the Michael addition an excess o f  methyl acrylate (75 equiv. per primary amine), was 
used. For the amidation steps, a large excess o f  ethylenediamine (100 equiv. per ester 
function) was required to prevent dendron bridging and gelation. Repeating these two 
steps led to a controlled synthesis o f  the desired dendrons.
Scheme [3.3]: Synthesis of FC2G1.5. Reagents and conditions: Methyl acrylate, MeOH,
reflux 24 h.
The dendrons terminated with methyl esters were easily purified with column 
chromatography (eluent DCM/MeOH) to give moderate or good yields (FC2G0.5 = 77%, 
FC2G1.5 = 70%, FC2G2.5 = 67%). In each case the purity o f  the ester terminated 
dendrons, (i.e. FC2G0.5, FC2G1.5 and FC2G2.5) was confirmed by HPLC (Figures 3.2- 
3.4). However, flash column chromatography could not be used to purify the amine 
species (FC2G1, FC2G2) because o f  their high polarity. Instead, the excess
o t
ethylenediamine (b.p. = 118 C) was removed azeotropically using a toluene:methanol 
mixture (9:1) before the amines (FC2G1, FC2G2) were dried in vacuo. The amines were 
purified by flash column chromatography using a mixture o f DCM and Me0 H/NH40 H as 
eluent. They are then synthetically pure to use further.
n ^ / ^ q d o  c h ,
N -^ S ^ C D O  CH,
FC2G1 FC2G1.5 (D O  CH,
41
Chapter Three: Fluorescent PAMAM Carriers
56%
FC2G1.5 OOOCH,
NH,
°^NH
O
I n^ nh,
O^NH
Scheme [3.4]: Synthesis of FC2G2. Reagents and conditions: MeOH/DCM, EDA, stirring 5
days/N2.
The structures o f  FC2G0.5, FC2G1.5 and FC2G2.5 were confirmed by FT-IR and NMR 
spectroscopy. The most characteristic IR peak for structure identification is that 
originating from the carbonyl stretch at 1730-1750 cm '1. The IR data showed regular 
alternation o f  the absorbance o f  the carbonyl group in the fluorescent dendrons. In the 
case o f  the half generations (FC2G0.5, FC2G1.5 and FC2G2.5), the ester carbonyl peak 
appeared around 1730-1750 cm '1 and the ester C-O stretching peak appeared at around 
1260 cm '1. For the full generations, methyl ester groups were converted to amide groups 
and the corresponding carbonyl peak shifted to 1640-1660 cm '1. The ’H-NMR data are 
summarized in the experimental section. They corroborated well with the FT-IR data to 
confirm the structure o f  the fluorescent dendrons. For example, the methyl ester proton 
peak (6 3.7) appeared in all the NMR spectra o f  the half generation dendrons but was 
absent in the spectra o f  all the full generations.
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COOCH,
HjCOOC
IOOCH,
COOCH.
COOCH.
COOCH.
NH. (■ '— COOCH. 
H,COOC
Scheme [3.5]: Synthesis of FC2G2.5. Reagents and conditions: Methyl acrylate, MeOH, reflux
All the dendrons o f  interest were characterized and their structures verified by 'H-NMR, 
l3C-NMR, EI-MS, and MALDI-TOF MS with all results agreeing with the proposed 
structures.f2l4]
3.1.3 Synthesis of fluorescent PAMAM dendritic wedge salts 
FC2G0.5, FC2G1.5 and FC2G2.5 ( -COONa).
While PAMAM dendrimers have many biomedical applications, it is anionic PAMAM 
dendrimers which are o f  particular current interest as drug delivery vehicles.[216] This is 
because they have the important advantage o f  being non-cytotoxic compared to the 
cationic dendrimers,[217] whilst also being highly effective in transcellular transport and 
oral delivery applications. For example, previous studies in cancer cells have shown that 
efficacy o f  anionic PAM AM  dendrim er-methotrexate (MTX) conjugates were 
significantly better than cationic PAMAM dendrimer-M TX conjugates.t2l8] This 
difference has been partially attributed to differences in lysosomal residence times and 
intracellular drug release from anionic and cationic dendrimer-*lrug conjugates. Hence 
anionic PAMAM dendrimers may be more effective in-vivo platforms for drug delivery
2 days.
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applications compared to cationic PAMAM dendrimers, because o f  their better 
cytotoxicity profiles, and reduced protein binding.[219] Therefore, conversion o f  FC2G0.5 
diester to the anionic FC2G0.5 salt was attempted, and indeed achieved with very good 
yields (95%) by refluxing in ethanolic NaOH (Scheme 3.6).
H
CDO CHj
95%
(D O  CHj
^CD O N a
N
(D O N a
FC2 QQ,9 FCaSO.Ssalt
Scheme [3.6] Synthesis of FC2G0.5 salt. Reagents and conditions: Ethanolic NaOH, EtOH,
reflux 16 h.
Similarly, the other two anionic salts FC2G1.5 and FC2G1.5 were formed, in quantitative 
yield, by the alkaline hydrolysis o f  polyesters FC2G1.5 and FC2G1.5, respectively, by 
stirring with ethanolic NaOH at room temperature (Schemes 3.7, 3.8). All the compounds 
were fully characterized using by 'H-NMR, 13C-NMR, EI-MS, and MALDI-TOF MS.
IO CH, 10 Na
97%
N -^ V -C D O  CH,
F C 2 G 1 .5  s a l t'O CH, >0 Na
Scheme [3.7]: Synthesis of FC2G1.5 salt. Reagents and conditions: NaOH, EtOH, stirring
24 h, rt.
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h 3c o o c
COONa
COONaCOOCH,
‘COONa‘COOCH,
N
H 93%
V—V H
0  N
COONaCOOCH3
COOCH, NH
FCI ggit
NaOOC
Scheme [3.8]: Synthesis of FC2G2.5 salt. Reagents and conditions: NaOH, EtOH, stirring
24 h, rt.
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3.2. Photophysical characterization
As noted in the introduction, 1,8-naphthalimide derivatives are good candidates for 
fluorescent studies because o f  their intrinsic photophysical and photochemical 
properties,1220* which account for their widespread use as fluorescent dyes*137 2211 and 
fluorescent markers.*151,222'2231
3.2.1. UV-vis absorp tion  properties
The UV/visible absorption spectrum o f  FC2 in methanol at room temperature shows 
absorption in the near UV region at Xmax = 390 nm. Substitution o f  the bromine atom at C- 
3 in FC2 with an electron-donating alky lam ino group (compounds FC2G0 -  FC2G2.5 and 
their salts) results in a large bathochromic shift into the visible region at Xmax = 444-460 
nm (Figure 3.5). This is a typical effect for conjugated organic compounds and agrees 
with the reported literature.*213*
FC2
 FC2G0
 FC2G0.5
 FC2G0.5 salt
 FC2G1
-  FC 2G 15
 FC2G1 5 salt
 FC2G2
 FC2G2.5
 FC2G2.5 salt
0.2
470 490 510370 390 410 430
W avelength  (nm )
450 530 550350
Figure [3.5]: UV absorbance spectra for FC2 and FC2Gs in MeOH solvent.
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3.2.2. F luorescence m easurem ents.
3.2.2.1 Relative intensity o f fluorescence for PAMAM terminated [-COOMe, - 
NH2].
As described earlier, the aminoethyl derivative FC2 GO-NH2 was chosen for study due to its 
suitability as a starting material for building PAMAM dendrons. The RFI characteristics 
o f  the fluorophore 3-aminobenzimidazo[2,l-a]benz[de]isoquinolin-7-one derivatives, FC2 
and FC2G0-FC2G2.5, in methanol are presented in (Figures 3.6, 3.7) and show that the 
fluorescence emissions are in the spectral region 502-516 nm (Table 3.1). The effect o f 
the C-4 alkylamino substituent on the energy of the dyes’ fluorescence maximum 
wavelength is negligible as reportedJ224^ In all cases the shape and maxima o f  the 
fluorescence band do not depend o f the excitation wavelength, and the excitation spectra 
are identical to the corresponding absorption spectra.
FC2250
FC2 GO«r 200
FC 2G 1r. 150
FC2 G2« 100
FC2 GO.550
F C 2G 1.5
510 560
Wavelength (nm)
610460
FC2 G 2 .5
Figure [3.6]: Fluorescence emission curves of all FC2Gs compounds in MeOH at UV 
absorbance 0.05 x 1 0 "3, when excited at wavelength A.max 455 nm.
Despite the negligible effect on the wavelength o f the fluorescence transitions, the
fluorescence performance o f compounds FC2 and FC2G0-FC2G2.5 is clearly influenced by
the substituent at the C-3 position o f  the molecule (Figure 3.6, 3.7 and Table 3.1). The
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fluorescence intensity o f  core FC2 is very low in comparison with that o f  compounds 
FC2G0, FC2G1 and FC2G1.5, but is stronger than that o f  higher generations FC2G2, 
FC2G2.5.
250
200 -
150
100
FC2G0 FC2G0.5 FC2G1 FC2G1.5 FC2G2 FC2G2.5FC2
Figure [3.7]: Fluorescence Intensity values of all FC2G dendrons in MeOH at UV 
absorbance 0.05 x 10'3, when excited at wavelength \ max 455 nm
It has been explained previously that FC2 has low fluorescent intensity due to the bromine 
derivative on its C-3 position, which affects polarization o f  the 1,8-naphthalimide 
chromophoric system.11771
Table [3.1]: Fluorescence Intensity values of all FC2Gs compounds in MeOH at UV 
absorbance 0.05 x 1 0 3, when excited at wavelength Xmax 455 nm
Compounds FC2 FC2 GO FC2 GO.5 FC2G 1 F C 2G 1 .5 FC 2G 2 FC2 G 2.5
Emission max (nm ) 515.5 508.5 513.5 511.5 510 502 513
Fluorescence Intensity  
(a.u.)
31 224 81 79 65 21 11
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It was found that the fluorescence intensity spectra o f FC2G0 in methanol solution is eight 
times higher than FC2. There are two opposite factors influencing the fluorescent spectra 
o f  FC2G0. The strongest influence, which increases the fluorescence, is the presence o f 
the electron-donating amino group. It is known that the photophysical properties o f  the 
analogous 1,8-naphthalimide system depends mainly on the polarization o f  the molecule
The second and weaker influence is the photoinduced electron transfer (PET) phenomena. 
For this particular case, it was predicted that the PET process (an electron transfer from 
the primary amine receptor to the excited state o f  the fluorophore core) would quench
low due to the receptor being a primary amine rather than a tertiary amine for which the 
PET process is more favoured.12261
[FC2G0]
Figure [3.9]: Weak fluorescent quenching process result from PET in case of primary
amine receptor.
(Figure 3.8).1361
A bs
[FC2G0]
Figure [3.8]: Conjugation process pathways of compound FC2G0
fluorescence emission (Figure 3.9).[2251 However, the possibility ofPET happening is very
energy and electron transfer
Fluorophore Spacer Receptor
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As (Table 3.2) shows, the relative fluorescence intensity decreases from FC2G0 » >  
FC2G0.5 = FC2G1 > FC2G1.5 > FC2G2 > FC2G2.5. This trend is due to the effect o f  the 
tertiary amines within the PAMAM substitutent, which can interact with the fluorophore 
core via the PET mechanism (Figure 3.10)1225* and, as the PAMAM generation increases, 
the number o f  amines also increases, which enhances the PET process (Table 3.2).[181' 183]
energy and electron transfer
Abs
Flu
Fluorophore Spacer Receptor
[FC2G0.5]
Figure [3.10]: Strong fluorescent quenching process resulting from PET in the case of
tertiary amine receptor.
Table [3.2]: Number of primary, tertiary amines in all compounds FC2Gs.
Compounds
Name
Generation
Number
Primary amine 
-NH2
Tertiary amine 
=N-
Total no. of 
amines
FCGO 0 1 0 0
FC2G0.5 0.5 0 1 1
FC2G1 1 2 1 3
FC2G1.5 1.5 0 3 3
FC2G2 2 4 3 7
FC2G2.5 2.5 0 7 7
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3.2.2.2 Relative intensity for fluorescent PAMAM terminated [-COONa].
Figures (3.12 and 3.13) show how the relative fluorescence intensity decreases for the
carboxylate salts FC2G0.5 > FC2G1.5 »  FC2G2.5 due to the previously mentioned PET 
effect. The extra tertiary amine groups in the scaffold quench the fluorescence as the 
generation increases.11941
600
-  500
GO.5 salt
400
 G1.5 salt
£  300 -
 G2.5 salt
200
100
UL
500 550
W a v elen g th  (nm)
400 450 600 650 700
Figure [3.12]: Fluorescence emission curves for all FC2G0.5, FC2G1.5 and FC2G2.5 salts 
in H20  at UV absorbance 0.0379 when excited at wavelength Xmax 447 nm.
The RFI study o f  carboxylate terminated PAMAM dendron salts was carried out in water. 
This solvent was chosen due to its biological compatibility and its potential hydrogen- 
bonding capability with the terminal groups o f  the PAMAM dendrons. These H-bonds 
favour radiation-less transitions, which has previously been noted to cause a decrease o f 
the fluorescence quantum yield o f  the analogous 1,8-naphthalimide fluorophore.51 2271
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Figure [3.13]: Fluorescence intensity values of all FC2G0.5, FC2G1.5 and FC2G2.5 salts in 
H2O at UV absorbance = 0.0379 when excited at wavelength Xmax 447 nm.
3.2.3 E ffect o f concen tra tion  on fluorescence em ission intensity
The fluorescent emission intensity was measured for aqueous solutions o f  FC2G0.5, FC2G1.5 
and FC2G2.5 PAMAM dendron carboxylate salts at various concentrations at room 
temperature. It was found that the emission intensity increased almost linearly with 
concentration (Figures 3.15, 3.17, 3.19). This result suggests that there is no effect o f  
intermolecular interaction (i.e. self-quenching within aggregates) on the fluorescence 
properties o f  the dendrons over the concentration range 0.83 x 10'4 - 5.75 x 10"4 mM L '1 ,[226]
400 GO.5 salt Cone.
350
5  300 
§  250
 3.25 0-4 rrtV
200
 1.62 0-4 fi*i
---------1 08
100 ■
50 -
650400 450 500 550
Wavelength (nm)
600
Figure [3.14]: Fluorescence Intensity curves at 
different concentrations of FC2G0.5 salt in H20  at 
emission 500 nm at 25 °C.
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3 300 -
250 -
200  -
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GO 5 s a l
50 -
Concentration e-4 mM
Figure [3.15]: Fluorescence Intensity at different
concentrations of FC2G0.5 salt in H20  at emission 500 
nm at 25 °C.
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Figure [3.16]: Fluorescence Intensity curves at 
different concentrations of FC2G1.5 salt in H20  at 
emission 500 nm at 25 °C.
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Figure [3.17]: Fluorescence Intensity at different
concentrations of FC2G1.5 salt in H20  at emission 500 
nm at 25 °C.
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Figure [3.19]: Fluorescence Intensity at different 
concentrations of FC2G2.5 salt in H20  at emission 500 
nm at 25 °C.
3.2.4 In fluence o f pH on the absorption and fluorescence  
characteristics
3.2.4.1 UV-Visible Absorption Spectra
As a typical example for all compounds under study, the UV-Vis spectra o f FC2G0.5 salt 
was recorded in alkaline solution at pH 11. An absorption band was observed due to the 
internal charge transfer (ICT) state, with Xmax maximum at 456 nm (Figure 3.20). Upon 
acidification, the band was blue-shifted with small reductions in its maximum intensity at 
pH 5. However, upon further acidification (pH 3.5) the Xmax became red-shifted with very 
small intensity enhancements. These changes can be considered to be only minor in 
comparison to the changes in the fluorescence spectra (see later). As Gunnlaugsson et al.
Figure [3.18]: Fluorescence Intensity curves at 
different concentrations of FC2G2.5 salt in H20  at 
emission 500 nm at 25 °C.
G2.5 sa lt Cone.
 3.33 e-4 mM
 2 5 e 4 n # 4
 166 e-4 mM
 125 e-4 mM
480 530 580 630
Wavelength (nm)
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concluded for the analogous 1,8-naphthalimide fluorophores11641 the reason for the blue 
shift is twofold. First, the protonation o f the amine receptor (compound salts FC2G0.5, 
FC2G1.5, FC2G2.5) will exert some weak charge repulsion on the 4-amino moiety o f the 
fluorophore. Secondly, the major reason is that in strongly acidic conditions the push-pull 
character o f the ICT state is partially reduced due to the protonation o f  the 4-amino 
moiety itself (compound salts FC2G0.5, FC2G1.5, FC2G2.5)J224^
To conclude, in neutral, weakly acidic and weakly basic solutions, there are only minor 
changes in the spectra o f  the dendrons, but in highly basic solutions there are weak red 
shifts with higher absorbance at pH 11 then weak absorbance at pH 13.5. In highly acidic 
solutions there are red shifts (Figure 3.20). Similar behaviour was observed for solutions 
o f FC2G1.5 and FC2G2.5 (Figures 3.21, 3.22), and simple explanation presented by 
(Figure 3.23).
GO.S salt0.35
0.3
pH = 2 340.25
--------------  pH = 3.67
--------------  pH = 7.51
0.15
pH = 8 OB
0.1 • pH =8 31
0.05
pH = 13 57
- 0.1
550350 400
Figure [3.20]: UV absorbance at different pH values for FC2G0.5 salt in H20  at
concentration 16.66 x 10 3 mM.
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Figure [3.21]: UV absorbance at different pH values for FC2G1.5 salt in H20  at
concentration 16.66 x 1 0 3 mM.
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Figure [3.22]: UV absorbance at different pH values for FC2G2.5 salt in H20  at concentratio
16.66 x l0 '3 mM.
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Figure [3.23]
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3.2.4.2 Influence of pH on the fluorescence of FC2G0.5, FC2G1.5 and 
FC2G2.5 salts
The fluorescence o f  the carboxylate-terminated PAMAM dendrons (FC2G0.5, FC2G1.5 
and FC2G2.5) showed significant pH dependence over the pH range 13 to 1 as shown in 
(Figures 3.24-3.29). For FC2G0.5, when the pH decreased from 13 to 7, there was little 
change in the emission intensity. However, as the pH was reduced further, there appeared 
a rapid increase o f fluorescence intensity, which reached a maximum at about pH 6; the 
emission band position scarcely changed during this process. Similarly, the fluorescence 
intensity o f  both FC2G1.5 and FC2G2.5 increased gradually as the pH was lowered from 
13 to 7, where the maximum intensity was achieved at about pH 6. Then the fluorescence 
intensity gradually decreased as pH was decreased further.12261
pH values of 
G0.5 sa lt soln.500
450 ■ 
4 0 0 -3
■i 350-
1 00
 2.61
300
 5 7 2
 7.7.5250
200 -
1 5 0 -
C  100 12.46 
 13.1250 -
660 70C500 550
W avslsngth (nm)
600400 450
Figure [3.24]: Fluorescence Intensity curves at
different pH values of FC2G0.5 salt in H20  when 
excited at wavelength Xmax 447 nm. at 25 °C and 
concentration 2.3 x 1 0 3 mM.
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♦  G O .5  s a l t
—  4 0 0  -
♦  ♦
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Figure [3.25]: Fluorescence Intensity at different pH 
values of FC2G0.5 salt in H20  when excited at 
wavelength Xmax 447 nm. at 25 °C and concentration 
2.3 x 10‘3 mM.
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pH values of 
G1.5 salt soln.
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Figure [3.26]: Fluorescence Intensity curves at 
different pH values of FC2G1.5 salt in H20  when 
excited at wavelength A™* 460 nm. at 25 °C and 
concentration 2.3 x 10'3 mM.
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Figure [3.27]: Fluorescence Intensity at different pH
values of FC2G1.5 salt in H20  when excited at 
wavelength Amax 460 nm at 25 °C and concentration 
2.3 x 1 0 3 mM.
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Figure [3.28]: Fluorescence Intensity curves at Figure [3.29]: Fluorescence Intensity at different pH
different pH values of FC2G2.5 salt in H20  when values of FC2G2.5 salt in H20  when excited at
excited at wavelength A™,, 445 nm. at 25 °C and wavelength A,™ 445 nm. at 25 °C and concentration
concentration 2.3 xlO'3 mM. 2.3 x 10‘3 mM.
For all dendrons the changes are o f such magnitude that they can be considered as 
representing two different “states”, where the fluorescence emission is “switched o ff’ in 
alkaline solution or strongly acidic solution and “switched on” in mildly acidic solution 
(Figure 3.30, 3 .3 l).[224] It is worth noting that pH 6 is the critical point in (Figures 3.25, 
3.27, 3.29) which correlates well with the pKa value[228‘229^ o f tertiary amines in PAMAM 
dendrimers. More acidic solutions (i.e. below pH 3) result in further protonation of the 
imidazole unit causing losses in fluorescence, as has been noted for other imidazole- 
containing fluorophores.[ l99'200’ 203l
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energy and electron transfer
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Figure [3.30]: Quenching and enhancement of fluorescenceof FC2G0.5 salt in presence 
of strong acidic and weak acidic media respectively.
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Figure [3.31]: Enhancement and quenching of fluorescenceof FC2G0.5 salt in presence of 
weak acidic and strong basic media respectively.
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3.3. Physicochemical Characterization Studies 
3.3.1. Pulsed Gradient Spin Echo - NMR ((PGSE) -  NMR)
The PAMAM dendrimers have a flexible and loose structure allowing the interior 
hydrophilic branches to fold outward in water J 55, 881 The three fluorescent PAM AM-  
COONa terminated (FC2G0.5, FC2G1.5, FC2G2.5) dendrons can be considered as 
amphiphilic molecules with hydrophobic fluorescent aromatics at the core and hydrophilic 
interior branches at the periphery (COONa). Their potential aggregation behaviour in D 20  
was hence investigated.
3.3.1.1 Self-diffusion Coefficient (Ds).
Using date acquired from pulsed gradient spin echo (PGSE) NMR by PhD student 
Abdulhakim Jangher o f  the group o f  Dr. Peter Griffiths (Cardiff University), the self- 
diffusion coefficient, Ds, are calculated from equation ( l)  using the measured peak 
integral, A (G, 3) as a function o f  field gradient duration (3) and ramp time (a), intensity 
G , and separation A. Where y is the magnetogyric ratio o f  the nucleus under observation, 
in this case, protons.
A(G,S) = A0 e x p [- / G ----------------------------- —-----------------------------  D, \ (1)
V
The Ao term is determined by the number o f  protons in the sample and the first 
exponential term is the attenuation from spin-spin relaxation during the experiments. 
Typically values o f  3, A and a  for the polymer systems studied here are (d/>) = 200 psec, 
(d2) = 400 msec.
Table (3.3) and (Figure 3.32) show the diffusion coefficient (Ds) values for FC2G0.5, 
FC2G1.5 and FC2G2.5 fluorescent dendrons at different concentrations (9.0 - 23 mM L '1). 
In each case a modest decrease o f  the diffusion coefficient (Ds) is observed as the
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concentration increases. In the case o f  FC2G0.5, the values o f  the diffusion coefficient 
(Ds) are relatively large compared to those o f FC2G1.5 and FC2G2.5 which are very 
similar to each other.
Table [3.3]: Self diffusion coefficient (Ds) values of FC2G0.5, FC2G1.5 and FC2G2.5 
fluorescent dendron salts in D20  at 25 °C at different concentrations (9.0 - 23 mM L'1) at
pH (9 .3-9 .8).
FC2G0.5 FC2G1.5 FC2G2.5
Concentration (mM  L’1) I V  m V Concentration(m M  L’1) Ds/ mV Concentration(m M  L'1) D,/ m V 1
9.0 1.92 e'10 9.5 1.40 e 10 9.3 1.38 e 10
14.65 1.85 e*10 14.65 1.37 e 10 14.6 1.27 e 10
18.90 1.76 e 10 19.20 1.36 e 10 18.9 1.25 e 10
23.5 1.69 e 10 22.15 1.31 e 10 23.5 1.15 e 10
2 .2 e -1 0
G 0.5 
G 1.5 
G 2.5
2 .0 e -1 0
1 .8 e -1 0
1 .6 e -1 0
1 .4 e -1 0
1 .2 e -1 0
1 .0 e -1 0  -
8 .0 e -1 1
Concentration I mM
Figure [3.32]: Self diffusion coefficient (Ds) curves of FC2G0.5, FC2G1.5 and FC2G2.5 
fluorescent dendron salts in D20  at 25 °C at different concentrationse (9.0 - 23 Mm L'1).
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3.3.1.2 Hydrodynamic radii (Rh).
The hydrodynamic radius (Rh)  values o f  the three fluorescent PAMAM-COONa 
terminated (FC2G0.5, FC2G1.5, FC2G2.5) dendrons as a function o f  concentration was also 
investigated by diffusion NMR. As a characteristic length, the hydrodynamic radius is 
calculated by Stokes-Einstein equation (2).
Where kg is the Boltzmann constant, T  is the temperature in Kelvin, rj is the viscosity o f  
the solvent and Rh is the hydrodynamic radius o f the fluorescent dendron.
Table [3.4]: Hydrodynamic radii (Rh) values of FC2G0.5, FC2G1.5 and FC2G2.5 fluorescent 
dendrons salt in D2O at 25 °C at different concentrations (9.0 -  23 mM L"1).
F C 2 G 0 .5 F C 2 G 1 .5 F C 2 G 2 .5
Concentration/mM L'1 Rh/A Concentration/ mM L'1 Rh/A Concentration/ mM L"1 Rh/A
9.0 10.1 9.5 13.8 9.3 14.0
14.65 10.4 14.65 14.1 14.6 15.2
18.90 11.0 19.20 14.2 18.9 15.5
23.5 11.4 22.15 14.8 23.5 16.8
Table (3.4) shows the expected increase in the hydrodynamic radius (Rh) o f FC2G2.5 > 
FC2G1.5 > FC2G0.5 studied as a function o f  the dendrimer generation at constant 
concentration (Figure 3.33).
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Figure [3.33]: Hydrodynamic radii (Rh) curves of FC2G0.5, FC2G1.5 and FC2G2.5 
fluorescent dendron salts in D20  at 25 °C at different concentrations (9.0 - 23 mM I 1).
These studies demonstrate that over this relatively high concentration range (as compared 
to those used in the fluorescence studies) the diffusion coefficients o f  FC2G0.5, FC2G1.5 
and FC2G2.5 do not vary significantly so there is no sign o f  aggregation. The 
hydrodynamic radii have been obtained using the Stokes-Einstein equation extrapolated to 
infinite dilution Ds. The size o f  the dendrons were not significantly altered at different 
concentrations.
3.4. Conclusion
In conclusion, we designed and prepared several new water soluble fluorescent dendrons 
and studied their photophysical and physicochemical properties. The dendrons are all 
fluorescent due to the core but this is modulated by PET process which increases with 
higher PAMAM dendron generation.
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For all compounds the fluorescence is linearly correlated with concentration and the pH o f 
the aqueous solvent has a significant effect for both UV absorbance (ground state) and 
fluorescent emission (excited state). In strong acidic media this is due to protonation o f  
the core, while in basic media the fluorescent emission is quenched due to presence o f  the 
PET process involving the tertiary amine groups within the PAMAM units. The strongest 
fluorescent emission o f  all carboxylate-terminated dendrons was in pH 6. Generally 
physicochemical studies indicate that the self diffusion coefficient and hydrodynamic 
radii are unaffected by concentration suggesting that there is no aggregation.
The confirmed properties (i.e. water solubility, high fluorescence at near neutral pH, and 
no aggregation) suggest these new dendron are promising for the collaborative biological 
studies described in (Appendix A).
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Chapter Four: Experimental
4.1 Experimental techniques
4.1.1 Materials
Commercially available chemicals were purchased from Sigma-Aldrich or Acros 
Organics/Fisher Scientific and solvents were used without further purification. 
Anhydrous dichloromethane was obtained by distillation over calcium hydride under 
nitrogen atmosphere. Anhydrous V,V-dirnethylformamide was received from Aldrich. 
All reactions involving air/moisture sensitive reagents were performed in oven-dried, 
under a nitrogen atmosphere. TLC analysis refers to analytical thin layer 
chromatography, using aluminum-backed plates coated with Merck Kieselgel 60 
GF254. Product spots were viewed by the quenching o f  UV fluorescence. Flash 
chromatography was performed on silica gel 60A (35-70 micron) chromatography 
grade (Fisher Scientific).
4.1.2 Instruments 
Melting Point
Melting points were recorded using a Gallenkamp Melting Point Apparatus.
Infra Red spectra (IR)
Infrared spectra were recorded in the range 4000-600 cm' 1 using a Perkin-Elmer 1600 
series FTIR instrument either as a thin film or as a nujol mull between sodium 
chloride plates. All absorptions are quoted in cm '1.
Nuclear Magnetic Resonance (NMR)
]H and 13C NM R spectra were recorded in DMSO-d6 (unless otherwise stated) using 
an Avance Bruker DPX 400 instrument (400 MHz) or an Avance Bruker DPX 500 
(500 MHz). All chemical shifts reported in (<5, ppm) with referenced to (TMS, S 0.0).
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Mass spectrometry
Low-resolution mass spectrometric data were determined using a Fisons VG Platform 
II quadrupole instrument using electrospray ionisation (ES) unless otherwise stated. 
High-resolution mass spectrometric data were obtained in electrospray (ES) mode 
unless otherwise reported, on a Waters Q-TOF micromass spectrometer. Matrix 
Assisted Laser Desorption - time o f  flight Mass Spectrometry (MALDI-TOF) is 
available using a Waters Maldi Micro MX research grade instrument.
Elemental analyses
Elemental analyses were obtained from University o f  Warwick Analytical Service 
facility. CHN Analysis CE440 Elemental Analyser, Bromine is analysed using 
classical oxygen flask methods. The methods have been fully developed to allow for 
interference correction from other elements including mixed halogens.
Ultra Violet (UV)
Absorption spectra were recorded on a JASCO (V-570) UV/Vis/NIR 
spectrophotometer.
Luminescence fluorometer
Fluorescence emission spectra were measured in the range 200-900 cm' 1 with a 
Perkin-Elmer (LS 55 precisely) Luminescence spectrometer.
High Performance Liquid Chromatography (HPLC)
HPLC (UVD 170U) used for separation, column [250 X 10.00 nm, 10 micro -  Silica
c,8].
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Compounds FC2 G0.5, G1.5, G2.5 were purified by preparative HPLC according to 
the following setup programme for Pharmacokinetic studies.
Time %CH3CN TFA (0.02%) H 20
1 0.00 4.0 1.0 95
2 5.00 4.0 1.0 95
3 12.00 98.0 1.0 1.0
4 14.00 98.0 1.0 1.0
5 16.00 4.0 1.0 95
Compounds FC2 GO, G l, G2 were purified by preparative HPLC according to the 
following setup programme for DNA binding studies.
Time %MeOH TFA (0.02%) H 20
1 0.00 4.0 1.0 95
2 5.00 4.0 1.0 95
3 12.00 98.0 1.0 1.0
4 18.00 98.0 1.0 1.0
5 20.00 4.0 1.0 95
4.2. General experimental procedures
4.2.1. Photolumiscence study procedures
4.2.1.1. Quantum yield determination
The compounds under study were prepared as solutions in DMF at concentrations that 
give a UV absorbance value o f  0.7. The fluorescence quantum yields o f  the 
compounds were measured according to the comparative method o f  Williams et 
al.[230] which involves the use o f well characterised standard samples with known 
fluorescence quantum yield (Of) values. Using 2-aminopyridine as the reference 
compound (Op =  60* l O'2 in 0.1 M H2SC>4)[23^  for compound CF2 and fluorescein as 
the reference compound (OF =  79x 10'2 in 0.1 M NaOH)l232] for compounds 3, A3, B3, 
C3, C33. Standard 10 mm path length fluorescence cuvette was used for running the 
fluorescence measurements with the concentration range never exceeding an effective
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adsorption o f 0.1 at the maximum excitation wavelength. In order to minimise re­
absorption effects (Dhami et al.),[233J the fluorescence spectra o f all compounds were 
determined under the same operation conditions and settings with 2.5 slit widths. 
Fluorescence quantum yields were determined by comparing the integral areas o f  the 
fluorescence emission for the different compounds.
4.2.1.2 pH measurements
For the first sample, the pH was lowered blow 1 and fluorescent spectra were 
collected approximately every 1 pH unit until the pH reached around 13. pH 
adjustments were made using NaOH and HC1 0.1M (Merck) to avoid possible 
fluorescent interference from buffers. To decrease the dilution problem, small 
amounts o f  concentrated NaOH and HC1 were spiked. The volume o f  the samples was 
20 mL and the additions never exceeded 100 pL, which represents <1% o f  the initial 
volume.1234^
4.2.1.3 Fluorescent measurements
The samples were run on a Perkin-Elmer LS50B Luminescence Spectrometer 
connected to a personal computer and fitted with a xenon lamp with 20 kW pulses for 
8 ms duration. The quartz cell can contain 3mL o f sample. Fifty individual emission 
spectra were collected at excitation wavelengths 5 nm apart between 200 and 450 nm, 
and emission wavelengths ranging from 300 to 600 nm. The scanning speed was 
selected at 500 nm m in '1, and band pass widths were 15 nm for excitation and 
emission. Fluorescence emission intensities were done in arbitrary units and always 
automatically corrected by the measurement system for variations in the excitation 
lamp spectral profile and any temporal intensity variation. Fluorescence
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measurements were made at a regulated temperature, 231°C, because fluorescence is 
temperature-dependent.[234]
4.3. Experimental procedures
4.3.1. Organic synthesis procedures
2-(l-aminopropan-2-yl)-lH-benzo[de]isoquinoline-l,3(2H)-dione [CF2J.
d
c
c
1,8-Naphthalic anhydride [1] (4.80 g, 24 mmol) was added in portions to a solution o f 
1,2-propanediamine (2.45 mL, 28.8 mmol) in EtOH (250 mL) and the mixture was 
heated at reflux for 8 h. The mixture was filtered under partial vacuum and the filtrate 
was evaporated under reduced pressure. The residue was purified by flash column 
chromatography [CHCI3, MeOH, (10 : 0.1)] followed by HPLC (eluent: MeOH, H2O; 
90:10) to yield [CF2] as a bright yellow oil (3.27 g, 53%). UV (Xmax, nm): 432 
(DMF); IR  (Neat NaCl, cm '1): 3059, 2968, 2921, 1668, 1629, 1595; ‘H -N M R (500 
MHz; CDCI3): S  8.37 (d, lH a, J  = 7.2 Hz), 8.28 (d, Hb, J =  7.2 Hz), 7.93 (d, 2HC, J  = 
7.2 Hz), 7.51 (t, 2H d), 4.38 (m, 2He), 4.12 (t, lH f), 1.32 (d, 3Hg); 13C-N M R (125 
MHz; CDCI3): S 160.3 (C =0), 153.3 (C), 132.8 (CH), 132.1 (CH), 131.6 (CH), 129.0 
(C), 128.4 (CH), 126.7 (C), 126.5 (CH), 126.4 (CH), 124.3 (CH), 120.9 (C), 61.0 
(CH2), 50.6 (CH), 22.2 (Me); Anal. Calcd for (C i5H ,2N20 ): C, 76.25; H, 5.12; N,
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11.20. Found: C, 75.97; H, 4.83; N, 11.13; HRMS (EI+): m/z = 235.9801 (lvT, 
100%).
tert-butyl 2-(2-(2-(l,3-dioxo-lH  benzo[de]isoquinolin-2(3H)yl)ethoxy)ethoxy)- 
ethylcarbamate [CF3 Boc].
HoC CH
CH.
1,8-Naphthalic anhydride [1] (1.00 g, 5 mmol) was added in portions to a solution o f  
tert-butyl 2-(2-(2-aminoethoxy)ethoxy)ethylcarbamate [Boc NH] (1.55 g, 6.25 mmol) 
in EtOH (30 mL) and the mixture was heated at 80 °C for 1 h. The mixture was 
filtered under vacuum and the filtrate was evaporated under reduced pressure. The 
residue was purified by flash column chromatography [toluene, acetone, (10 : 0.5)] to 
give [CF3 Boc] as a pale yellow oil (1.78 g, 83%). IR (Neat NaCl, cm '1): 3374, 3063, 
2973, 2928, 1701, 1663, 1590, 1236; 'H-NMR (400 MHz; C D C I 3 ): 8 8.39 (d, 2Ha, J  
= 7.3 Hz), 7.98 (d, 2Hb, J =  7.3 Hz), 7.53 (t, 2HC, J =  7.3 Hz), 5.02 (s, 1H), 4.29 (t, 
2Hi), 3.71 (t, 2H2), 3.58 (t, 2H3), 3.49 (t, 2H4), 3.36 (t, 2H5), 3.12 (t, 2H6) 1.30 (s, 
9H7); ,3C-NM R (100 MHz; C D C I 3 ): S 164.1 (C=0), 156.0 (CONH), 133.9 (CH),
131.1 (CH), 129.0 (CH), 128.2 (C), 126.8 (C), 125.3 (C), 79.0 (C), 70.2 (CH2), 68.0 
(CH2), 40.4 (CH2), 39.0 (CH2), 28.4 (Me); Anal. Calcd for (C23H28N20 6): C, 64.47; 
H, 6.59; N, 6.54. Found: C, 64.47; H, 6.64; N, 6.53; HRMS (ES+): m/z = 429.2046 
(M + H+, 100%), 446.2456 (M + NH*+, 43%).
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2-(2-(2-(2-aminoethoxy)ethoxy)ethyl)-1 H-benzo [de] isoquinoline-1,3(2 H)-dione 
[CF3].
A solution o f  [CF3 Bocl (9.50 g, 22.1 mmol) in dichloromethane (15 mL) was added 
dropwise to trifluoroacetic acid (15 mL) at 0 °C. The reaction was allowed to warm to 
room temperature and stirred for 2 h under a nitrogen atmosphere, then the solvent 
was evaporated under reduced pressure. The residue was dissolved in an aqueous 
solution o f  potassium carbonate and extracted with dichloromethane (3 * 200 mL). 
The combined organic layers were dried with magnesium sulfate, filtered and 
evaporated under reduced pressure. The residue was purified by flash column 
chromatography [CHCI3 : MeOH : NH3 (9 : 1 : 0.1)] to afford (CF3] as a pale brown 
oil (7.00 g, 98%). UV (Xmax, nm): 383 (DMF); IR (Neat NaCl, cm '1): 3373, 3313, 
3061, 2869, 1698, 1660, 1587, 1113; 'H-NMR (400 MHz; CDC13): S  8.25 (d, 2Ha, J
= 7.1 Hz), 7.90 (d, 2Hb, J  = 7.1 Hz), 7.42 (t, 2HC, J  = 7.1 Hz), 4.17 (t, 2H,), 3.58 (t, 
2H2), 3.48 (t, 2H 3), 3.32 (t, 2H„), 3.19 (t, 2H5), 2.51 (t, 2H6) 1.06 (s, 2H); l3C-NMR  
(100 MHz; CDC13): 6 164.0 (C O ) , 133.8 (CH), 131.3 (CH), 131.0 (CH), 127.9 (C),
126.8 (C), 122.3 (C), 73.4 (CH2), 70.2 (CH2), 67.8 (CH2), 41.7 (CH2), 38.9 (CH2); 
Anal. Calcd for (C i8H20N2O4): C, 65.84; H, 6.14; N, 8.53. Found: C, 65.73; H, 6.03; 
N, 8.21; HRMS (EI+): m/z = 328.1425 (M \ 81%), 329.1537 (M+H+, 17%).
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General procedure (A) for synthesis of naphthalimide derivatives.
To a stirred solution o f  naphthalic anhydride derivative (1 equiv.) in glacial acetic 
acid was added, under an N 2 atmosphere, the primary amine derivative (1 equiv.) and 
sodium acetate (3 equiv.). The reaction mixture was brought to reflux and the 
reaction’s progress was monitored by TLC (CH3Cl:MeOH:AcOH; 9:1:0.1). The 
resulting precipitate was collected by hot filtration, washed with hot glacial acetic 
acid then with hot distilled water. The final products were dried in vacuum for 24 h.
4-(l,3-dioxo-lH,3H-benzo(de]isoquinoIin-2-yl)-benzoic acid [A1 ].
e
c
d
C O O Hd
ce
Following general procedure (A), 1,8-naphthalic anhydride [1] (1.98 g, 10 mmol), 4- 
aminobenzoic acid (1.37 g, 10 mmol) and AcONa (2.48 g, 30 mmol) were reacted in 
glacial acetic acid (60 mL) to afford [A l| as a off-white solid that was used without 
further purification (2.91 g, 92%). mp: > 300 °C; UV (Xmax, nm): 383 (DMF); IR  
(KBr, cm '): 3404, 3113, 1713, 1675, 1654, 1587, 1237; 'H-NMR (400 MHz; 
DMSO-ds): <5 8.52 (d, 2Ha, J  = 2.7 Hz), 8.50 (d, 2Hb, J =  2.7 Hz), 8.10. (d, 2HC, J  =
7.7 Hz), 7.91 (t, 2Hd, J  = 7.7 Hz), 7.55 (t, 2He); “ C-NM R (100 MHz; DMSO-d6): <5
166.8 (COO), 163.5 (C =0), 140.1(C), 134.5 (CH), 131.4 (CH), 130.7 (CH), 130.6 
(CH), 129.8 (C), 129.5 (C), 127.8 (C), 127.2 (CH), 122.4 (C); Anal. Calcd for 
(C 19H 11NO4): C, 71.92; H, 3.49; N, 4.41. Found: C, 71.48; H, 3.40; N, 4.30; HRMS 
(ES+): m/z = 316.0552 (M -H+, 100%).
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4-(5,8-dinitro-l,3-dioxo-lH,3H-benzo[delisoquinolin-2-yl)-benzoic acid |A2].
a
COOH
a
b
Following general procedure (A), 3,6-dinitro-l,8-naphthalic anhydride [2] (2.88 g, 10 
mmol), 4 -aminobenzoic acid (1.37 g, 10 mmol) and AcONa (2.48 g, 30 mmol) were 
reacted in glacial acetic acid (60 mL) to afford [A2J as a bright yellow solid that was 
used without further purification (3.78 g, 93%). mp: > 300 °C; UV (A,max, nm): 341 
(DMF); IR (KBr, cm '1): 3413, 3075, 1714, 1675, 1663, 1609, 1522, 1342; 'H-NMR 
(400 MHz; DMSO-d6): <5 9.75 (d, 2Ha, J  = 2.0 Hz), 9.06 (d, 2Hb, J  = 2.0 Hz), 8.09 (d, 
2HC, J  = 8.3 Hz), 7.54 (d, 2Hd, J  = 8.3 Hz); “ C-NM R (100 MHz; DMSO-d6): <5 166.7 
(COO), 161.7 (C =0), 147.1 (C-NO2), 147.0 (CH), 139.1 (C), 131.8 (CH), 131.5 (CH),
129.1 (C), 127.6 (C), 125.7 (C), 125.0 (CH); Anal. Calcd for (C19H9N3O8): C, 56.03; 
H, 2.23; N, 10.32. Found: C, 55.98; H, 2.06; N, 10.01; HRMS (E1+): m/z = 407.0391 
(M+, 100%).
4-(6-bromo-l,3-dioxo-lH-benzo(de]isoquinoIin-2(3H)-yl)benzoic acid [A4J.
COOH
Following general procedure (A), 4-bromo-l,8-naphthalic anhydride [4] (2.77 g, 10 
mmol), 4-aminobenzoic acid (1.37 g, 10 mmol) and AcONa (2.48 g, 30 mmol) were
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reacted in glacial acetic acid (60 mL) to afford [A4] as a pale yellow solid that was 
used without further purification (2.69 g, 68%). mp: above 300 °C; UV (A.max, nm): 
402 (DMF); IR (KBr, cm '1): 3418, 3070, 1710, 1681, 1607, 1610, 551; 'H-NMR (500 
MHz; DMSO-d6): S 8.54 (m, 2Ha), 8.30 (d, lHt* J  = 7.8 Hz), 8.20 (d, 1HC, J  = 7.8 
Hz), 8.10 (d, 2Hd, J  = 8.3 Hz), 7.99 (t, 1HC, J =  7.2 Hz), 7.55 (d, 2Hf, J  = 8.3 Hz); ,3C- 
NMR (125 MHz; DMSO-d6): S 166.8 (COO), 162.9 (C=0), 139.7 (C), 132.7 (CH),
131.5 (CH), 131.3 (CH), 130.9 (C-Br), 130.8 (CH), 129.8 (CH), 129.3 (C), 128.7 (C),
128.6 (C), 123.1 (CH), 122.3 (C); Anal. Calcd for (Ci9Hi0BrNO4): C, 57.60; H, 2.54; 
Br, 20.17; N, 3.54. Found: C, 57.33; H, 2.44; Br, 19.80; N, 3.44; HRM S (EI+): m/z = 
393.9583 (M71+, 100%), 395.9583 (M81+, 98%).
5-(l,3-dioxo-lH,3H-benzo[de]isoquinolin-2-yl)-isophthalic acid [Bl].
e
a
COOH
d
d
COOH
ae
Following general procedure (A), 1,8-naphthalic anhydride [1] (1.98 g, 10 mmol), 5- 
aminoisophthalic acid (1.81 g, 10 mmol) and AcONa (2.48 g, 30 mmol) were reacted 
in glacial acetic acid (60 mL) to afford [B l] as an off-white solid that was used 
without further purification (2.93 g, 92%). m p: > 300 °C; UV (2max, nm): 410 (DMF); 
IR (KBr, c m 1): 3440, 3071, 1770, 1698, 1626, 1587; 'H-NMR (400 MHz; DMSO- 
d6): S  8.55 (d, 2H„, J  = 6.2 Hz), 8.52 (s, 2Hb), 8.50 (s, 1 Hc), 7.92 (d, 2Hd, J  = 6.2 Hz), 
7.85 (t, 2He); IJC-NM R (100 MHz; DMSO-d6): <5 169.2 (COO), 164.0 (C=0), 140.4 
(CH), 136.9 (CH), 134.8 (C), 132.3 (C), 131.7 (CH), 128.2 (C), 127.5 (CH), 125.1
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(C), 122.9 (CH), 114.6 (C); Anal. Calcd for (C2oH nN 06): C, 66.44; H, 3.07; N, 3.88. 
Found: C, 66.17; H, 3.15; N, 3.43; HRMS (EI+): m/z = 361.0585 (M \ 64%).
5-(5,8-dinitro-l,3-dioxo-lH,3H-benzo[de]isoquinolin-2-yl)-isophthalic acid (B2J.
COOH
COOH
Following general procedure (A), 3,6-dinitro-l,8-naphthalic anhydride [2] (2.88 g, 10 
mmol), 5-aminoisophthalic acid (1.81 g, 10 mmol) and AcONa (2.48 g, 30 mmol) 
were reacted in glacial acetic acid (60 mL) to afford [B2] as a pale yellow solid that 
was used without further purification (4.28 g, 95%). mp: > 300 °C; UV (^max, nm): 
419 (DMF); IR (KBr, c m 1): 3439, 3073, 1706, 1680, 1678, 1611, 1539, 1345; !H- 
NMR (400 MHz; D M SO -4): d 9.83 (d, 2Ha, J  = 1.9 Hz), 9.09 (d, 2Hb, J  = 1.9 Hz), 
8.58 (s, 1HC), 8.27 (s, 2Hd); l3C-NMR (100 MHz; DMSO-d*): 6 165.8 (COO), 161.9 
(C=0), 147.0 (C -N 02), 136.0 (CH), 134.1 (CH), 132.3 (C), 131.9 (C), 131.5 (C),
130.7 (C), 130.0 (C), 125.6 (CH), 125.2 (CH); Anal. Calcd for (C2oH9N3Oio): C, 
53.23; H, 2.01; N, 9.31. Found: C, 52.92; H, 2.51; N, 9.14; HRMS (EI+): m/z = 
451.0290 (M4, 6%).
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5-(6-bromo-l,3-dioxo-lH-benzo|de]isoquinolin-2(3H)-yl)isophthalic acid [B4J.
d a
COOH
COOH
b a
Following general procedure (A), 4-bromo-l,8-naphthalic anhydride [4] (2.77 g, 10 
mmol), 5-aminoisophthalic acid (1.81 g, 10 mmol) and AcONa (2.48 g, 30 mmol) 
were reacted in glacial acetic acid (60 mL) to afford [B4] as a pale yellow solid that 
was used without further purification (3.74 g, 85%). mp: > 300 °C, UV (2max, nm): 
408 (DMF), IR  (KBr, cm '1): 3392, 3086, 1713, 1670, 1585, 1610, 688; *H-NM R(400 
MHz; DMSO-d6): 6 8.60 (m, 3Ha), 8.35. (d, lH b, J  = 7.7 Hz), 8.29 (m, 3HC), 8.03 (t, 
lH d, J  = 7.7 Hz); ,3C -N M R  (125 MHz; DMSO-d6): S 166.0 (COO), 163.1 (C=0),
136.5 (C), 134.3 (CH), 132.7 (C), 132.1 (C-Br), 131.5 (CH), 130.8 (C), 129.7 (C),
129.2 (CH), 128.7 (C), 123.4 (CH), 122.6 (C); Anal. Calcd for (C20H,o B rN 06): C, 
54.57; H, 2.29; Br, 18.15; N, 3.18. Found: C, 54.67; H, 2.33; Br, 18.31; N, 3.25; 
H RM S (EI+): m/z = 438.9684 (M 71+, 78%), 440.9741 (M81+, 76%).
3-amino-5-(l,3-dioxo-lH,3H-benzo[de]isoquinolin-2-yl)-benzoic acid [Cl].
COOH
a
a
NH,
ad
Following general procedure (A), 1,8-naphthalic anhydride [1] (1.98 g, 10 mmol),
3,5-diaminobenzoic acid (1.52 g, 10 mmol) and AcONa (2.48 g, 30 mmol) were 
reacted in glacial acetic acid (60 mL). The residue was purified by flash column
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chromatography (CHCI3 : MeOH : NH3; 9 : 1 : 0.1) to afford [Cl] as an off-white 
solid (1.42 g, 43%). mp: above 300 °C; UV {Xmax, nm): 422 (DMF); IR (KBr, c m 1): 
3472, 3317, 3125, 1731, 1705, 1663, 1613, 1236; *H-NMR (400 MHz; DMSO-d6): S 
10.31 (s, 1H), 8.52 (m, 4Ha), 8.22 (s, lH b), 7.92 (s, 1HC), 7.85 (t, 2Hd), 7.67 (s, lH e); 
13C-NMR (100 MHz; DMSO-d6): S 166.8 (COO), 166.4 (C=0), 164.1 (C-NH2),
137.2 (CH), 134.9 (C), 134.8 (C), 132.5 (C), 131.8 (C), 131.1 (C), 27.5 (CH), 123.7 
(CH), 123.0 (CH); Anal. Calcd for (Ci9H,2N202): C, 68.67; H, 3.64; N, 8.43. Found: 
C, 68.64; H, 3.60; N, 8.65; HRMS (EI+): m/z = 332.0800 (Mf, 100%).
3-amino-5-(5,8-dinitro-l,3-dioxo-lH,3H-benzo[de]isoquinolin-2-yl)-benzoic acid 
[C2[.
COOH
NH,
Following general procedure (A), 3,6-dinitro-l,8-naphthalic anhydride [2] (2.88 g, 10 
mmol), 3,5-diaminobenzoic acid (1.52 g, 10 mmol) and AcONa (2.48 g, 30 mmol) 
were reacted in glacial acetic acid (60 mL). The residue was purified by flash column 
chromatography (CHCI3 : MeOH : NH3; 9 : 1 : 0.1) to afford [C2] as a pale brown 
solid (0.50 g, 12%). mp: > 300 °C; UV (? w , nm): 455 (DMF); IR (KBr, cm '1): 3368, 
3077, 1720, 1676, 1633, 1577, 1413, 1336; 'H-NM R (500 MHz; DMSO-d6): S 10.21 
(s, 1H), 9.81 (d, 2Ha, J  = 2.1 Hz), 9.08 (d, 2Hb, J  = 2.1 Hz), 8.02 (s, 1HC), 7.99 (s, 
lH d), 7.58 (s, lH e), 2.08 (s, 2H); ,3C-NMR (125 MHz; DMSO-d6): 6 171.9 (COO),
168.7 (C O ) ,  166.4 ( C O ) ,  166.0 (C -N 02), 161.8 (C-NH2), 147.0 (C), 146.9 (CH),
140.0 (CH), 133.9(C), 131.9(C), 130.6 (C), 125.7 (C), 124.2 (CH), 123.2(C), 119.6
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(C); Anal. Calcd for (C 19H,oN408): C, 54.04; H, 2.39; N, 13.27. Found: C, 54.37; H, 
2.75; N, 13.57; HRMS (EI+): m/z = 422.0489 (VT, 100%).
3-amino-5-(6-bromo-l,3-dioxo-lH-benzo[de]isoquinolin-2(3H)-yl)benzoic acid 
[C4].
COOH
NH,
Following general procedure (A) 4-bromo-l,8-naphthalic anhydride [4] (2.77 g, 10 
mmol), 3,5-diaminobenzoic acid (1.52 g, 10 mmol) and AcONa (2.48 g, 30 mmol) 
were reacted in glacial acetic acid (60 mL). The residue was purified by flash column 
chromatography (CHCI3 : MeOH : NH3; 9 : 1 : 0.1) to afford [C4J as a deep yellow 
solid (0.45 g, 11%). m p: > 300 °C; UV (A™ax, nm): 428 (DMF); IR  (KBr, cm '1): 3445, 
3337, 3076, 1728, 1707, 1669, 1613, 872; *H-NMR (400 MHz; DMSO-d6): S  10.05 
(s, 1H), 8.60 (m, 2Ha), 8.37 (d, lH b, J  = 7.8 Hz), 8.28 (d, 1HC, J  = 7.8 Hz), 8.09 (s, 
lH d), 8.04 (t, lH e), 7.81 (s, lH f), 7.52 (s, lHg), 2.05 (s, 2H); 13C-NMR (100 MHz; 
DMSO-d6): S 168.7 (COO), 166.5 (C=0), 163.0 (C), 140.0 (CH), 136.2 (CH), 132.7 
(C), 131.95 (CH), 131.5 (C-Br), 131.3 (C), 130.8 (CH), 129.8 (C), 129.1 (C), 128.8 
(C), 124.6 (C), 123.5 (CH), 122.6 (CH), 119.5 (CH); Anal. Calcd for 
(Ci9HiiBrN204): C, 55.50; H, 2.70; Br, 19.43; N, 6.81. Found: C, 55.19; H, 2.93; Br, 
19.31; N, 6.67; HRMS (EI+): m/z = 409.9912 (M7I+, 100%), 411.9868 (M 81+, 98%).
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General procedure (B) for synthesis of naphthalimide derivatives.
To a stirred solution o f  naphthalic anhydride derivative (2 equiv) in glacial acetic acid 
was added, under an N 2 atmosphere, the primary amine derivative (1 equiv.) and 
sodium acetate (6 equiv.). The reaction mixture was heated to reflux and the reaction 
progress was monitored by TLC (CH3CI : MeOH : AcOH; 9 : 1 : 0.1). The resulting 
precipitate was collected by hot filtration, washed with hot glacial acetic acid then 
with hot distilled water. The final products were dried in vacuum for 48 h.
3,5-bis-(l,3-dioxo-lH,3H-benzo[de]isoquinolin-2-yl)- benzoic acid [Cl 1).
COOH
Following general procedure (B), 1,8-naphthalic anhydride [11 (3.96 g, 20 mmol),
3,5-diaminobenzoic acid (1.52 g, 10 mmol) and AcONa (4.96 g, 60 mmol) were 
reacted in glacial acetic acid (100 mL). The residue was purified by flash column 
chromatography (CHCI3 : MeOH : NH3; 9 : 1 : 0.1) to afford [Cl 1] as a pale yellow 
solid (3.84 g, 75%). Mp > 300 °C; UV ().max, nm): 405 (DMF); IR (KBr, c m '): 3460, 
3072, 1695, 1673, 1626, 1587; 'H-NMR (400 MHz; DMSO-d„): 6 10.83 (s, 1H), 8.51 
(m, 8Ha), 8.23 (s, 2Hb), 7.80 (m, 4HC), 7.54 (s, lH d); l3C-NMR (100 MHz; DMSO- 
ds): 6 172.0 (COO), 169.1(C=0), 166.7 (C=0), 140.4 (CH), 137.0 (CH), 134.8 (C),
131.1 (C), 130.6 (CH), 127.6 (C), 125.1 (C), 124.0 (C), 122.9 (CH), 119.8 (CH);
C c
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Anal. Calcd for (C3iHi6N20 6): C, 72.66; H, 3.15; N, 5.47. Found: C, 72.60; H, 3.05; 
N, 5.77; HRMS (EI+): m/z = 512.1020 (M \ 38%).
3,5-bis-(5,8-dinitro-l,3-dioxo-lH,3H-benzo[de]isoquinolm-2-yl)-benzoic acid [C22].
COOH
0 oN NO.
n o 2 n o2
Following general procedure (B), 3,6-dinitro-l,8-naphthalic anhydride [2] (5.76 g, 20 
mmol), 3,5-diaminobenzoic acid (1.52 g, 10 mmol) and AcONa (4.96 g, 60 mmol) 
were reacted in glacial acetic acid (100 mL). The residue was purified by flash 
column chromatography (CHCI3 : MeOH : NH3; 9 : 1 : 0.1) to afford [C22] as a pale 
yellow solid (4.91 g, 71%). m p: > 300 °C; UV ( ? w  nm): 342 (DMF); IR  (KBr, cm' 
'): 3399, 3079, 1725, 1686, 1612, 1535, 1315; ‘H-NMR (400 MHz; DMSO-d6): <5 
9.75 (s, 4Ha), 9.12 (s, 4H„), 8.22 (s, 2HC), 7.82 (s, lH d); IJC-NMR (100 MHz; 
DMSO-d6): <5 172.0 (COO), 166.4 (C O ) , 162.3 (C -N 02), 147.3 (CH), 136.3 (CH),
133.1 (C), 132.3(C), 131.9(C), 131.1 (C), 130.8(C), 126.1 (CH), 125.4 (CH); Anal. 
Calcd for (C31H |2N 6014): C, 53.77; H, 1.75; N, 12.14. Found: C, 53.48; H, 1.76; N, 
11.74; HRMS (EI+): m/z = 692.0405 (M+, 3%).
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3,5-bis(6-bromo-l,3-dioxo-lH-benzo|de]isoquinolin-2(3H)-yl)benzoic acid [C44].
COOH
e  e
Following general procedure (B), 4-bromo-1,8-naphthalic anhydride [4] (5.54 g, 20 
mmol), 3,5-diaminobenzoic acid (1.52 g, 10 mmol) and AcONa (4.96 g, 60 mmol) 
were reacted in glacial acetic acid (100 mL). The residue was purified by flash 
column chromatography (CHCI3 : MeOH : NH3; 9 : 1 : 0.1) to afford [C441 as a 
bright yellow solid (4.49 g, 67%). mp: > 300 °C; UV (Xmax, nm): 401 (DMF); IR 
(KBr, cm '1): 3418, 3094, 1709, 1677, 1586, 672; 'H-NMR (400 MHz; DMSO-d6): 6 
8.61 (m, 4Ha), 8.38. (d, 2Hb, J =  7.9 Hz), 8.28 (d, 2HC, J =  7.9 Hz), 8.14 (s, 2Hd), 8.03 
(dd, 2He, J  = 7.5, J =  0.8 Hz), 7.73 (s, lH f); 13C-NMR (100 MHz; DMSO-d6): 6 168.6 
(COO), 166.5 (C =0), 163.1 (C O ) ,  140.0 (CH), 136.3 (CH), 132.8 (CH), 131.6 (C),
131.3 (CH), 130.9 (C-Br), 130.3 (CH), 129.9 (C), 129.2 (C), 128.8 (C), 124.6 (C),
123.4 (CH), 122.6 (CH); Anal. Calcd for (C3iHi4BrN20 6): C, 55.55; H, 2.11; Br, 
23.84; N, 4.18. Found: C, 54.98; H, 2.01; Br, 23.31; N, 4.19; HRMS (EI+): m/z = 
393.9831 (M79+, 100%), 395.9892 (M81+, 98%), 668.9410 (M 158+, 18%), 669.9470 
(M 160+, 29%), 671.9366 (M 162+, 16%).
General procedure (C) for synthesis of naphthalimide derivatives.
A mixture o f  3,6-dinitro-l,8-naphthalimide derivative (0.339 mmol), Pb/C 10% (0.05 
g) and DMF (30 mL) was hydrogenated using hydrogen contained in a balloon at 
room temperature with vigorous stirring from 16 - 24 h. The progress o f the reaction
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was monitored by TLC (CHC^iMeOHiAcOH; 8:2:0.5). The catalyst was filtered o ff 
and the filtrate was poured into DCM (250 mL) with stirring. The solid precipitate 
was collected by filtration.
4-(5,8-diamino-l,3-dioxo-lH,3H-benzo[de]isoquinolin-2-yl)-benzoic acid [A3J.
d
COOH
d
b
Following general procedure (C), [A2] (0.138 g, 0.339 mmol) and Pb/C 10% (0.05 g) 
were hydrogenated in DMF (30 mL) for 16 h to afford [A3] as a deep brown solid 
without further purification (0.10 g, 91%). mp: > 300 °C; UV (Xmax, nm): 518 (DMF); 
IR (KBr, cm '1): 3438, 3349, 3224, 3066, 1703, 1666, 1605; 'H-NMR (400 MHz; 
DMSO-d6): 3 8.09 (d, 2Ha, J =  8.5 Hz), 7.58 (d, 2Hb, J =  2.0 Hz), 7.47 (d, 2HC, J  = 8.5 
Hz), 6.99 (d, 2Hd, J  = 2.0 Hz) 5.72 (br s, 4H); 13C-NM R (100 MHz; DMSO-d6): 3
166.9 (COO), 164.2 (C -O ), 162.2 (C-NH2), 147.6 (C), 140.4 (CH), 135.6 (C), 130.7 
(C), 129.5 (CH), 122.6 (C), 117.0 (CH), 114.9 (CH), 109.9 (C); Anal. Calcd for 
(C ,9H i3N 304): C, 65.70; H, 3.77; N, 12.10. Found: C, 65.34; H, 4.20; N, 11.87; 
HRMS (ES+): m/z = 347.0905 (M +, 100%).
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5-(5,8-diamino-l,3-dioxo-lH,3H-benzo[de]isoquinolin-2-yl)-isophthalic acid [B3|.
COOH
COOH
Following general procedure (C), [B2] (0.153 g, 0.339 mmol) and Pb/C 10% (0.05 g) 
were hydrogenated in DMF (30 mL) for 16 h to afford [B3] as a yellowish brown 
solid that was used without further purification (0.12 g, 92%). Mp > 300 °C; UV 
(A™x, nm): 518 (DMF); IR (KBr, cm '1): 3462, 3382, 3224, 3083, 1694, 1626, 1567; 
'H-NM R (500 MHz; DMSO-d6): S 8.51 (s, lH a), 8.12 (s, 2Hb), 7.60 (d, 2HC, J  = 1.3 
Hz), 6.98 (d, 2Hd, J  = 1.3 Hz) 5.5 (br s, 4H); ,3C-NMR (125 MHz; DMSO-d6): S
166.1 (COO), 164.1 (C=0), 162.2 (C-NH2), 147.5 (C), 140.4 (CH), 135.6 (C), 130.7 
(CH), 129.5 (CH), 122.7 (C), 118.0 (CH), 114.9 (CH), 110.7 (C); Anal. Calcd for 
(C20H 13N3O6): C, 61.38; H, 3.35; N, 10.74. Found: C, 61.17; H, 3.64; N, 11.10; 
LRMS (ES+): m/z = 391.34 (M+, 19%).
3-amino-5-(5,8-diamino-l,3-dioxo-lH-benzo[de]isoquinolin-2(3H)-yl)benzoic 
acid [C3J.
NH
e
e
COOH
H.'2
Following general procedure (C), [C2] (0.143 g, 0.339 mmol) and Pb/C 10% (0.05 g) 
were hydrogenated in DMF (30 mL) for 24 h to afford [C3] as a yellow solid (0.11 g,
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94%), after purification by flash chromatography (CHCl3:MeOH:AcOH; 8:2:0.5). 
mp > 300 °C; UV nm): 521 (DMF); IR  (KBr, c m 1): 3459, 3365, 3228, 3092, 
1697, 1657, 1625; 'H -N M R  (500 MHz; DMSO-d6): 8  8.24 (s, 1H„), 7.78. (s, lH b), 
7.60 (d, 2HC, J  = 1.8 Hz), 7.58 (s, lH d), 6.98 (d, 2He, J  = 1.8 Hz), 5.77 (br s, 6H); 13C- 
N M R (125 MHz; DMSO-d6): 8 168.6 (COO), 164.0 (C =0), 147.6 (C-NH2), 139.9 (C- 
NH2), 136.7 (C), 135.6 (C), 124.6 (C), 123.4 (C), 122.6 (C), 122.6 (CH), 119.3 (CH),
117.0 (CH), 114.9 (C), 109.8 (CH); Anal. Calcd for (C 19H 14N4O4): C, 62.98; H, 3.89; 
N, 15.46. Found: C, 62.65 ; H, 3.95 ; N, 15.72 ; HRM S (EI+): m/z = 362.1026 (M+, 
16%).
3,5-bis(5,8-diamino-l,3-dioxo-lH-benzo[de]isoquinolin-2(3H)-yl)benzoic acid 
[C33].
COOH
NH.
NH, NH,
Following general procedure (C), [C22J (0.234 g, 0.339 mmol) and Pb/C 10% (0.10 
g) were hydrogenated in DMF (60 mL) for 24 h to afford [C33J as a greenish yellow 
solid (0.17 g, 89%), after purification by flash chromatography 
(CHCl3:MeOH:AcOH; 8:2:0.5). mp: above 300 °C; UV (A,max, nm): 518 (DMF); IR 
(KBr, c m 1): 3442, 3361, 3228, 3079, 1698, 1660, 1625; 'H -N M R  (500 MHz; 
DMSO-db): 8  8.01 (s, 2H a), 7.63. (s, lH b), 7.60 (d, 4HC J  = 1.7 Hz), 6.97 (d, 4Hd 7  =
1.7 Hz), 5.78 (s br, 8H); l3C-N M R (125 MHz; DMSO-d6): 8 173.5 (COO), 166.3 
(C =0), 164.0 (C =0), 147.6 (C-NH2), 136.9 (C), 135.6 (CH), 130.0 (C), 129.3 (C),
83
Chapter Four: Experimental
122.6 (CH), 120.3 (CH), 116.9 (CH), 114.9 (CH), 109.8 (C); Anal. Calcd for 
(C3iH2oN60 6): C, 65.03; H, 3.52; N, 14.68. Found: C, 64.90; H, 3.74; N, 14.95; 
HRMS (EI+): m/z = 572.3426 (M*, 11%).
3-bromo-7H-benz[de]benzimidazo[2,l-a]isoquinoline-7-one. [FC2J.
c
The mixture o f  4-bromo-l,8-naphthalic anhydride (0.277 g, 0.001 mol) and o- 
phenylenediamine (0.2 g, 0.002 mol) was dissolved in acetic acid (50 mL). The 
resulting solution was allowed to reflux for 2 h, the mixture was cooled to room 
temperature, and then poured into distilled water to precipitate the product as a bright 
yellow powder. About (0.18 g, 54%) o f [FC2] was obtained after twice recrystallised 
from toluen. mp: 253-254 °C according to Lit.;[199] UV (l max, nm): 390 (MeOH); IR 
(KBr, c m 1): 1696 (O O ) , 746 (C-Br); ’H-NMR (500 MHz; CDC13): 6 8.86 (dd,
lH a, J  = 1.4 and 7.2 Hz), 8.68 (dd, lHb, 7 = 1 .4  and 7.2 Hz), 8.56 (m, 2HC), 8.10 (t, 
lH d), 7.91 (d, 2He, J  = 7.2 Hz), 7.49 (t, 2Hf); ,3C-NMR (125 MHz; CDC13): 6 193.3 
(0 = 0 ), 144.0 (C), 143.4(C), 141.3 (CH), 138.4 (C), 133.7 (CH), 133.1 (CH), 131.4 
(C), 131.2 (C), 130.5 (C), 130.2 (CH), 128.9 (CH), 128.6 (C), 127.5 (C-Br), 127.4 
(CH), 123.2 (CH), 115.3 (CH); HRMS (EI+): m/z = 347.9909 (M71+,100%), 351.03 
(M8I++H, 98%).
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3-(2-aminoethylamino)-7H-benz[de]benzimidazo[2,l-a]isoqumoline-7-one.
[FC2G0].
Method TA1
Compound (FC2] (0.6099 g, 1.747 mmol) and ethylenediamine (1.2 mL, 18.02 mmol) 
were stirred in refluxing MeCN (10 mL) for 3 days. The orange precipitate was 
collected by hot filtration and stirred in ether for 16 h, then filtered, and dried. The 
orange solid was recrystallized from toluene to give (0.084 g, 14%) a pale orange 
powder [FC2G01 after flash column chromatography (DCM:MeOH; 10:0 - 8:2).
Method FBI
Compound [FC2] (0.6022 g, 0.002 mol) was suspended in ethylenediamine (6.68 mL, 
0.1 mol) and the resulting suspension was heated to 130 °C for 1 h., the mixture was 
cooled to 95 °C and poured into distilled water at 90 °C. After stirring and cooling to 
room temperature, the deep red suspension was filtered and washed with water. The 
solid was dried and recrystallized from toluene twice to give (0.12 g, 19%) as deep 
red crystals [FC2G01 after flash column chromatography (DCM:MeOH; 10:0 - 8:2), 
It was purified further by HPLC as described in the Section 4.1.2. mp: 212-213 °C;
UV (A/max? nm): 433 (MeOH); IR (KBr, cm '1): 3530(-NH2), 2900 (-CH2-), 1677 
(C =0); 1 H-NMR (500 MHz; MeOD): 8 8.82 (d, lH a, J =  7.3 Hz), 8.66 -  8.54 (m,
3
9 H 2
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2Hb), 8.04 (d, 1HC, J  = 8.3 Hz), 7.90 (d, lH d, J  = 8.3 Hz), 7.67 (t, lH e), 7.47 (t, 2Hf), 
6.71 (d, lH g, J =  8.5 Hz), 6.31 (s , lH h), 3.37 (q, 2Hi), 3.17 (t, 2H2), 1.31 (br s, 2H3); 
,3C-NMR (125 MHz; MeOD): S 142.5 (C), 141.4 (C), 141.1 (C), 135.2 (C), 133.7 
(CH), 130.6 (C), 128.4 (C), 127.6 (CH), 124.5 (CH), 124.0 (CH), 123.9 (C), 123.1 
(CH), 122.0 (CH), 121.8 (C), 116.1 (CH), 111.9 (CH), 45.7 (CH2), 39.5 (CH2); 
HRMS (ES+): m/z = 329.1401 (MH+, 100%).
FC - PAMAM Dendron - G1
O 1 NH2
3 / - N  
/ ----- /  H
N
4 V - N  
o
5 N H 2
A solution o f  [FC2G0.5] (0.5 g, 0.001 mol) in (MeOHrDCM; 5:15 mL) was added 
dropwise over 30 min to a cooled (0 °C) solution o f  ethylenediamine (13.38 mL, 0.2 
mol) (100 equiv/COOMe) in MeOH (30 mL) and a small amount o f  DCM was added 
until the solution cleared. The reaction was stirred for 2 days under nitrogen at room 
temperature. The bulk o f  the solvent and excess ethylenediamine were removed via 
rotary evaporation. Final traces o f  excess ethylenediame were removed azeotropically 
using a mixture o f  toluene and MeOH (9:1) (this was repeated several times until all 
traces o f  ethylenediamine had been removed). The product was dried thoroughly 
under high vacuum (1 mmHg) then was purified by flash column chromatography 
(DCM :MeOH:NH40H; 9: 1: 0.2) to obtain (0.32 g, 57%) o f  [FC2G1J as a pink oil, It
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was purified further by HPLC as described in the Section 4.1.2. UV (Amax, nm): 445 
(MeOH); IR (Neat, cm '1): 3284 (-NH2), 3075 (Ar-H), 2942 (-CH2-), 1675 (N -C =0), 
1572 (N H -C =0); *H-NMR (500 MHz; MeOD): 8 8.14 (d, lH a, J  = 7.3 Hz), 7.98 (d, 
lHb, J  = 7.3 Hz), 7.76 (d, 1HC, J -  8.6 Hz), 7.70 (d, lH d, J =  8.6 Hz), 7.54 (d, lH e, , J  
= 8.7 Hz), 7.28 (t, 2Hf),7.08 (t, lHg), 6.02 (d, lH h, J  = 8.7 Hz), 3.22 (t, 4H,), 3.03 (t, 
2H2), 2.82 (t, 4H3), 2.69 (m, 6H4), 2.41 (t, 4H5); 13C-NMR (125 MHz; MeOD): 3
173.6 (CONH), 159.5 (C), 150.9 (C), 149.0 (C), 142.5 (C), 134.4 (CH), 131.1 (C),
127.6 (C), 126.3 (CH), 125.1 (CH), 124.6 (CH), 123.8 (C), 123.7 (CH), 119.8 (CH),
118.2 (C), 115.4 (CH), 107.6 (CH), 103.6 (CH), 49.3 (CH2), 48.5 (CH2), 43.3 (CH2),
41.6 (CH2), 40.6 (CH2), 33.3 (CH2); HRMS Calc, for (C30H36N8O3): 556.2983, found 
556.2977 (M+, 100%).
FC - PAMAM Dendron - G2
NH,
°< ^ N H
O 3
O NH
A solution o f  [FC2G1.5] (0.9 g, 0.001 mol) in MeOH (30 mL) was added dropwise 
over 30 min to a cooled (0 °C) solution o f ethylenediamine (26.76 mL, 0.4 mol) (100
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equiv/COOMe) in MeOH (70 mL). The reaction was stirred for 5 days under nitrogen 
at room temperature. The bulk o f the solvent and excess ethylenediamine were 
removed via rotary evaporator. Final traces o f excess ethylenediame were removed 
azeotropically using a mixture o f toluene and MeOH (9:1) (this was repeated several 
times until all traces o f  ethylenediamine had been removed). The product was dried 
thoroughly under high vacuum (1 mmHg) then was purified by flash column 
chromatography (DCM :M e0H:NH40H; 9: 1: 0.2) to obtain (0.57 g, 56%) o f 
polyamine [FC2G2J as a red oil, It was purified further by HPLC as described in the 
Section 4.1.2. UV nm): 433 (MeOH); IR  (Neat, cm '1): 3262 (-NH2), 3075 (Ar- 
H), 2929 (-CH2-), 1675 (N -C =0), 1557 (N H -C O ); 'H -N M R  (500 MHz; MeOD): 
S  8.21 (d, lH a, / =  6.7 Hz), 8.12 (d, lH b,./=  6.7 Hz), 7.92 (d, 1HC, J  = 7.3 Hz), 7.84 
(d, lH d, J  = 6.9 Hz), 7.59 (d, lH e, J  = 6.9 Hz), 7.34 (t, 2Hf), 7.20 (t, lHg), 6.12 (d, 
lH h, J  = 7.3 Hz), 3.22 (t, 12H,), 3.07 (t, 2H2), 2.83 (t, 4H3), 2.70 (t, 18H4), 2.48 (t, 
4H S), 2.41 (t, 4H6), 2.28 (t, 8H7); ,3C-NM R (125 MHz; MeOD): 6 173.5 (CONH),
173.0 (CONH), 164.4 (C), 159.6 (C), 151.1 (C), 149.2 (C), 142.8 (CH), 134.6 (C),
131.3 (C), 127.8 (CH), 126.5 (CH), 126.4 (CH), 124.7 (C), 124.0 (CH), 120.0 (CH),
118.4 (C), 115.5 (CH), 107.8 (CH), 103.8 (CH), 52.1 (CH2), 49.7 (CH2), 49.4 (CH2),
48.6 (CH2), 43.6 (CH2), 41.7 (CH2), 40.8 (CH2), 37.3 (CH2), 33.4 (CH2); M ALDI- 
T O F  [LD+] Calc, for (CsofysN^Or): 1013.6170, found 1013.674 (M*, 100%).
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General procedure (D) for synthesis of polyesters GO.5. G1.5. G2.5
Methyl acrylate (75 equiv/NH2 function) was added to a solution o f  conjugate with 
amine terminal groups and the mixture was heated to reflux. MeOH and the excess o f  
methylacrylate were eliminated to yield the polyester after chromatography using 
silica gel as substrate and a mixture o f  CHCI3 and MeOH (10:0.1) as eluent.
FC - PAMAM Dendron -  G0.5
3 ^COOCH3 1
N
Methyl acrylate (6.75 mL, 0.075 mol) was added to a solution o f [FC2G0J (0.328 g, 
0.001 mol) in MeOH (40 mL) and the mixture was heated to reflux for 6 h, then 
stirred for 16 h at room temperature, filtered, washing with MeOH, and dried. The 
orange solid was recrystallized from MeOH to give (0.084 g, 77%) a bright orange 
solid [FC2G0.5] after flash column chromatography (DCM:MeOH; 10:0 -  10:0.2), It 
was purified further by HPLC as described in the (Section 4.1.2). mp: 170-171 °C; 
UV ( lmax, nm): 445 (MeOH); IR (KBr, cm '1): 3413 (-NH), 3058 (Ar-H), 2950 (-CH2- 
), 2848 (-OCH3), 1734 (-COOCH3), 1681 (N -C =0), 1581 (N H -C =0); 'H-NMR (400 
MHz; CDCI3): S  8.54 (d, lH a, J  = 7.2 Hz), 8.46 (d, lH b, J  = 7.2 Hz), 8.24 (d, 1HC, J  
= 7.2 Hz), 7.93 (d, lH d, J  = 8.4 Hz), 7.74 (d, 1HC, J  = 8.4 Hz), 7.38 (t, lH f), 7.30 (t, 
2Hg), 6.30 (d, 1 Hh, J  = 7.2 Hz), 6.09 (s, 1H), 3.40 (s, 6H,), 3.05 (t, 2H2), 2.61 (t, 4H3),
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2.52 (t, 2H4), 2.29 (t, 4H5); 13C-NM R (100 MHz; CDC13): S 172.7 (COO), 160.5 (C),
150.6 (C), 149.8 (C), 143.7 (C), 134.9 (CH), 131.9 (C), 128.3 (C), 126.8 (CH), 124.9 
(CH), 124.8 (CH), 124.5 (C), 120.5 (CH), 119.9 (CH), 119.3 (C), 115.9 (CH), 109.4 
(CH), 104.3 (CH), 51.5 (Me), 51.4 (CH2), 48.8 (CH2), 40.1 (CH2), 32.4 (CH2); LRM S 
(ES+): m/z = 501.21 (MH+, 100%), 502.22 (33%), 503.22 (6%); HRM S Calc, for 
(C28H28N405): 500.2060, found 500.2139 (M+, 100%).
FC - PAM AM  D endron -  G1.5
?
COOCHj 1
8 N 
H
N
g H 5 V " \ - N
0  4 N'^s^CO O CH ,
6S
CO OCH3
Methyl acrylate (13.5 mL, 0.15 mol) was added to a solution o f [FC2G1] (0.556 g,
0.001 mol) in MeOH (30 mL) and the mixture was heated to reflux for 24 h, then 
stirred for 16 h at room temperature. MeOH and excess o f methylacrylate were 
eliminated by heating under reduced pressure to yield the [FC2G1.5] as a deep orange 
oil (0.63 g, 70%) after purification by flash column chromatography (DCM:MeOH; 
10:0 -  10:0.3), It was purified further by HPLC as described in the (Section 4.1.2). 
UV (Xmax, nm): 445 (MeOH); IR  (KBr, cm '1): 3306 (-NH), 3039 (Ar-H), 2918 (-CH2- 
), 2851 (-OCHj), 1729 (-COOCH3), 1674 ( N O O ) ,  1589 (N H -C =0); 'H -N M R  (400
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MHz; MeOD): <5 8.16 (d, lH a, J =  7.5 Hz), 8.13 (d, lH b, J =  7.5 Hz), 7.93 (d, 1HC, J  = 
0.54 Hz), 7.86 (d, lH d, J  = 8.5 Hz), 7.49 (d, lH e, J  = 8.5 Hz), 7.19 (m, 3Hf), 6.30 (d, 
lH g, J  = 0.54 Hz), 3.40 (s, 12H,), 3.03 (t, 2H2), 2.97 (t, 4H3), 2.67 (t, 4H4), 2.57 (t, 
2H5), 2.42 (t, 8H6), 2.23 (m, 8H7), 2.14 (t, 8H8); ,3C-N M R (100 MHz; MeOD): 3
173.2 (CONH), 173.1 (COO), 159.9 (C), 151.3 (C), 149.4 (C), 142.7 (C), 134.8 (CH),
131.3 (C), 128.0 (C), 126.6 (CH), 125.6 (CH), 124.8 (CH), 124.0 (C), 120.2 (CH),
118.6 (CH), 118.3 (C), 115.5 (CH), 107.9 (CH), 104.0 (CH), 52.2 (CH2), 51.0 (CH2),
50.7 (Me), 49.3 (CH2), 48.9 (CH2), 40.9 (CH2), 37.0 (CH2), 33.3 (CH2), 32.0 (CH2); 
HRM S (EI+) Calc, for ^ H eo N g O ,,) : 900.4454, found 900.4453 (M \ 100%).
FC - PAM AM  D endron - G2.5
1 H3COOC
7 ^  — COOCH3
0
O
O 
8
9
O" 'NH
i l ).N
ii>
H3COOC
COOCH,
COOCK
H \
CO O CK
C O O CK
-COOCK
Methyl acrylate (27 mL, 0.30 mol) was added to a solution o f  [FC2G2] (1.01 g, 0.001 
mol) in MeOH (30 mL) and the mixture was heated to reflux for 2 days. MeOH and 
excess o f  methylacrylate were eliminated by heating under reduced pressure to yield
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the [FC2G2.5] as a deep orange oil (1.3 g, 76%) after flash column chromatography 
(DCM:MeOH; 10:0 - 10:0.3), It was purified further by HPLC as described in the 
(Section 4.1.2). UV ( ? w  nm): 445 (MeOH); IR  (KBr, c m 1): 3422 (-NH), 3043 (Ar- 
H), 2924 (-CH2-), 2850 (-OCH3), 1736 (-COOCH3), 1681 (N -C =0), 1581 (N H- 
C=0); ‘H -N M R (400 MHz; MeOD): S 8.46 (d, lH a, J = 7.2 Hz), 8.40 (d, lHb, 7.2 
Hz), 8.24 (d, lHe, 7 = 8 .5 ) , 8.20 (d, lH d, J =  8.5 Hz), 7.72 (d, lH e, J =  8.8 Hz), 7.49 (t, 
lH f), 7.42 (t, 2Hg), 6.50 (d, lH h, J =  8.8 Hz), 3.62 (s, 24Hi), 3.25 (t, 4H2), 3.20 (t, 
8H3), 2.90 (t, 4H4), 2.83 (t, 2H5), 2.74 (t, 8H6), 2.68 (t, I 6H7), 2.54 (t, 4H8), 2.48 (t, 
14H9), 2.39 (t, I 6H 10), 2.31 (t, 8H n ); ,3C-NM R (100 MHz; MeOD): S 173.2 
(CONH), 173.1 (CONH), 173.0 (COO), 160.0 (C), 151.4 (C), 149.5 (C), 142.8 (C),
135.0 (CH), 131.4 (C), 128.3 (C), 126.8 (CH), 125.8 (CH), 124.9 (CH), 124.4 (C), 
124.2(CH), 120.4 (CH), 118.9 (C), 115.6 (CH), 108.1 (CH), 104.2 (CH), 52.3 (CH2),
52.0 (CH2), 51.1 (Me), 50.8 (CH2), 49.5 (CH2), 49.0 (CH2), 40.6 (CH2), 37.2 (CH2),
37.0 (CH2), 33.4 (CH2), 33.2 (CH2), 32.1 (CH2), 29.5 (CH2); M A LD I-TO F [LD+] 
Calc, for (C82H,24N ,6023): 1701.9554, found 1701.969 (M+, 100%).
FC - PAM AM  D endron -  G0.5 salt
N
4 COONa
COONa
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To NaOH (0.5 g, 12.5 mmol), dissolved in hot EtOH (40 mL), was added a solution of 
the [FC2G0.5] (1.2 g, 2.4 mmol) in EtOH (10 mL). The mixture was heated to reflux 
for 16 h. After cooling, a the precipitate was collected by filtration and recrystallized 
from wet EtOH to yield [FC2G0.5 salt] as a pale yellow solid (0.92 g, 95%). Mp > 
300 °C decomposed at 315 °C (TGA); UV (Xmax, nm): 445 (MeOH); IR (KBr, cm '1): 
3380 (-NH), 3067 (Ar-H), 2956 (-CH2-), 1666 (-COONa), 1681 (N -C O ) , 1571 
(N H -C =0); 'H-NM R (400 MHz; MeOD): 6 8.47 (dd, lH a, 7  = 7.3, 7  = 0.7 Hz), 8.38 
(d, lH b, 7 = 7 .3  Hz), 8.33 (d, 1HC, 7 = 8 .7 ) , 8.28 (d, lH d, 7 =  8.6 Hz), 7.69 (d, lH e,7  =
8.6 Hz), 7.56 (t, lHf), 7.45-7.35 (m, 2Hg), 6.60 (d, lH h, 7 =  8.7 Hz), 3.44 (t, 2H,), 2.95 
(t, 4H2), 2.89 (t, 2H3), 2.48 (t, 4H0; 13C-NMR (100 MHz; MeOD): 3 179.9 (COO),
160.3 (C), 151.9 (C), 149.5 (C), 142.6 (C), 135.2 (CH), 131.3 (C), 128.3 (C), 126.8 
(CH), 126.1 (CH), 124.8 (CH), 124.3 (C), 124.0 (CH), 120.5 (CH), 118.5 (C), 118.2 
(CH), 115.5 (CH), 107.5 (CH), 50.7 (CH2), 50.4 (CH2), 40.5 (CH2), 35.1 (CH2); 
LRMS (ES+): m/z = 473.18 (MH+, 100%); HRMS Calc, for ( C ^ H ^ O s ) :  472.1872, 
found 473.1840 (MH+, 100%).
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FC - PAMAM Dendron - G1.5 salt
COONa
9 d n
g
H
N
N
H
5 N ^ /^ C O O N a
2 N \^ -C O O N a
COONa
To NaOH (1.0 g, 25 mmol), dissolved in absolute EtOH (100 mL), was added a 
solution o f [FC2G1.5] (2.23 g, 2.4 mmol) in EtOH (10 mL). The mixture was stirring 
for 24 h. at room temperature, and the precipitate was collected by filtration and 
recrystallized from wet EtOH to yield [FC2G1.5 salt] as a deep orange solid (2.17 g, 
97%). mp: 283 °C; UV (Xmax, nm): 445 (MeOH); IR (KBr, cm-1): 3362 (-NH-), 3079 
(Ar-H), 2968 (-CH2-), 1655 (-COONa), 1681 (N-C=0), 1571 (N H -C O ); ‘H-NMR  
(400 MHz; MeOD): S 8.47 (d, lH a, J  = 7.2 Hz), 8.41 (d, lH b, J  = 7.2 Hz), 8.29 (d, 
1HC, J =  3.5), 8.26 (d, lH d, J  = 8.7 Hz), 7.70 (d, lH e, J =  8.7 Hz), 7.53 (t, lH f), 7.48 
(m, 2Hg), 6.55 (d, lH h, J =  3.5 Hz), 3.40 (t, 2Hi), 3.33 (t, 4H2), 2.95 (t, 4H3), 2.85 (t, 
8H4), 2.62 (t, 4H5), 2.49 (t, 6H6), 2.36 (t, 10H7); 13C-NMR (100 MHz; MeOD): S
181.4 (COO), 174.7 (CONH), 162.7 (C), 153.2 (C), 150.9 (C), 144.1 (C), 142.3 (CH),
137.6 (C), 132.7 (C), 129.7 (CH), 127.3 (CH), 126.3 (CH), 125.7 (C), 123.4 (CH),
120.1 (CH), 119.7 (C), 117.0 (CH), 108.9 (CH), 105.5 (CH), 58.3 (CH2), 53.3 (CH2),
52.4 (CH2), 50.8 (CH2), 41.6 (CH2), 38.5 (CH2), 36.4 (CH2), 34.6 (CH2); MALDI- 
TOF [LD+] Calc, for (C42H 52N8On): 845.3756, found 845.2874 (W t, 100%).
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FC - PAMAM Dendron - G2.5 salt
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To NaOH (3.0 g, 75 mmol), dissolved in absolute EtOH (150 mL), was added a 
solution o f  [FC2G2.5] (4.23 g, 2.4 mmol) in EtOH (10 mL). The mixture was stirring 
for 24 h. at room temperature and the precipitate was collected by filtration and was 
recrystallized from EtOH to yield [FC2G2.5 salt] as a deep orange solid (3.9 g, 93%). 
mp: 269 °C; UV (/U „, nm): 445 (MeOH); IR (KBr, cm '1): 3412 (-NH-), 3091 (Ar-H), 
2956 (-CH2-), 1655 (-COONa), 1681 (N -C O ), 1571 (N H -C O ); 'H-NMR (500 
MHz; MeOD): <5 8.52 (d, lH a, J =  7.2 Hz), 8.43 (d, lHb, J  = 1 2  Hz), 8.33 (m, 2HC), 
7.72 (d, 1H* J = 7 . 5  Hz), 7.56 (t, lH e), 7.42 (m, 2Hf), 6.60 (d, lH g, J  = 7.5 Hz), 3.32 
(m, 14H,), 2.85 (m, 28H2), 2.59 (m, 14H3), 2.37 (m, 28H4); UC-NM R (125 MHz; 
MeOD): 6 181.4 (COO), 174.7 (CONH), 174.6 (CONH), 161.9 (C), 153.4 (C), 151.1 
(C), 144.3 (C), 142.5 (CH), 136.9 (C), 132.9 (C), 128.7 (CH), 127.6 (CH), 126.4 
(CH), 125.6 (C), 122.2 (CH), 120.4 (CH), 119.9 (C), 117.0 (CH), 109.4 (CH), 105.8
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(CH), 58.3 (CH2), 53.3 (CH2), 52.0 (CH2), 50.9 (CH2), 42.2 (CH2), 38.5 (CH2), 38.4 
(CH2), 36.5 (CH2), 34.8 (CHi), 34.5 (CH2); M ALDI-TO F |LD +1 Calc, for 
(C74Hi08Ni6O23): 1588.7773, found 1588.27 (M*, 100%).
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4.4. Experimental Appendix
Table |4.1|: UV maximum absorbance for FC2 and FC2Gs in MeOH solvent.
Compounds FC2 FC2G 0 FC2G0.5 FC 2G 1 FC2G1.5 FC 2G 2 FC2G2.5
UV max (nm) 383 444 447 455 449 460 447
Table [4.2]: Fluorescence Intensity at different concentrations o f FC2G0.5 salt in
H2O at max wavelength 443 nm at 25 °C.
Concentration e-4 mM 1 08 1.62 2.16 3.25 4.33
Fluorescence Intensity 99.86 142.8 192.84 282.21 368.06
Table [4.3]: Fluorescence Intensity at different concentrations o f  FC2G1.5 salt in 
H2O at max wavelength 456 nm at 25 °C.
Concentration e-4 mM 1-43 1.91 2.87 3.83 5.75
Fluorescence Intensity 85.58 112.1 164.91 215.98 313.36
Table [4.4]: Fluorescence Intensity at different concentrations o f  FC2G2.5 salt 
H2O at max wavelength 467 nm at 25 °C.
in
Concentration e-4 mM 0.83 1.25 1.66 2.5 3.33
Fluorescence Intensity 73.33 105 136.74 196.99 255.45
Table [4.5]: UV absorbance at different pH values for FC2G0.5 salt in H2O at 
concentration 16.66 x 10'3 mM.
PH 0.86 1.43 2.34 3 .57 5.05 7.51 8 .09 9.31 11.13 12.86 13.57
^ i ( n m ) 479 474 455 442 443 443 444 445 456 454 455
A b s . 0.22 0.20 0.14 0.11 0.20 0.23 0.23 0.21 0 .27 0 .23 0 .15
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Table |4.6]: UV absorbance at different pH values for FC2G1.5 salt in H20  at 
concentration 16.66 x 10'3 mM.
PH 0.83 1.32 2.15 3.87 5.86 7.43 9.63 10.7 11.16 12.17 12.88 13.56
^MAX
(nm)
482 470 447 443 445 448 457 460 462 459 457 455
A b s . 0.30 0.27 0.28 0.26 0.32 0.33 0.34 0.42 0.40 0.39 0.36 0.27
Table [4.7]: UV absorbance at different pH values for FC2G2.5 salt in H20  at 
concentration 16.66 x 10*3 mM.
pH 0.73 1.29 2.12 2.88 3.73 5.89 7.71 10.52 11.77 12.47 13.46
XMAX( nm) 479 461 447 445 445 448 455 467 468 468 459
Abs. 0.27 0.28 0.28 0.22 0.24 0.26 0.28 0.30 0.34 0.34 0.27
Table [4.8]: Fluorescence Intensity at different pH values o f  FC2G0.5 salt in H20  at 
max wavelength 447 nm at 25 °C and concentration 2.3 xlO'3 mM.
pH values 0.26 1.0 1.96 2.61 4.26 5.72 7.75 8.39 10.03 11.44 12.46 13.12
Flu
Intensity
33.55 34.21 82.58 146.5 349.1 493.6 361.7 361.1 146.6 20.31 16.66 11.45
Flu Em
max
554 549 497 499 501 501 501 501 503 516 516 516
Table [4.9]: Fluorescence Intensity at different pH values o f  FC2G1.5 salt in H20  at 
max wavelength 447 nm at 25 °C and concentration 2.3 x 10'3 mM.
pH values 0.4 0.98 1.62 1.92 2.7 3.72 5.57 7.9 8.24 10.12 11.29 1235 13.11 13.83
Flu Intensity 42.8 42.57 70.19 110.5 113.8 224.5 380.7 246.4 209.3 3727 29.15 28.99 24.94 123
Flu Em max 554. 550.5 502.5 500.5 502.5 503 502.5 503 502.5 516 515 515 513.5 515.5
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Table [4.10]: Fluorescence Intensity at different pH values o f  FC2G2.5 salt in H20  at 
max wavelength 447 nm at 25 °C and concentration 2.3 x 10'3 mM.
pH values 0 .55 1.05 2 .17 4.35 5.41 7.89 8 .1 5 9 .93 11.29 12.24 13.11 13.83
Flu
Intensity
55.04 90 .78 298.6 375.3 464.9 315 .3 211.8 75.49 64.43 63.62 62.56 47.03
Flu Em 
max
553.5 501 500 .5 500 501 503 504 .5 514.5 515 513 513.5 515
Table [4.11]: Extinction Coefficient o f all thesis’ compounds.
C om p.
No. Structure
uv
\nax abso(nm)
E x tin c t io n
C o e ff ic ie n t
(L  m ol'1 cm '1)
1 s s 330 13066.83
2
J S L .
277 30865.96
3 J 3 L, 278 33537.6
4 339.5 13029.4
CF1 334 13997.8
CF2 339.5 13946.66
CF3 334 12574.0
A1 g ^ - O 0 0 H 334 14693.6
A2 ^ ^ 1 - Q - cooh 269.5 44050.5
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A4 342 17801.0
B1 8*<fV_f t )  C 0 0 H 334 17344.5
B2
y / 1  COOH
272.5 32368.8
B4
COOH
342 16317.0
C1 8 R 334.5 13785.8
C2
COOH
o 2n
269.5 12012.6
C4 • m 342 18880.5
C11
COOH
334.5 27678.246
C22
COOH
272 75707.27
044
COOH
342 33701.402
3 J3i, 278 33537.6
A3 j^OoH 440 46648.3
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B3 I
COOH
438 3959.77
C3
" & < $y y  o cooh
h2n
432 6809.62
C33
co<b
nh2 nh.
435 14107.1
FC2 395 12429.4
FC2O0 <^ * v 9k A N^ NH2
H
457 8018.56
FC2G1
h y-N
o V~ \ h2
454 18645.0
FC2G2
JJ,
°yMH 
O y<N J
C ^ hh*
0 NH
NH,
460 9623.43
FC2G0.5 9 3 & ) ^^ COOCH, 
H COOCH3
457 12591.8
FC2G1.5
^JIOOCH,
X j T I M ^ I  0 N^/^COOCH,
VV ' A 'Vl!^0 N'N_,COOCHj
I^ooch,
461 23311.5
0 2 .5
H.COOC
(^-COOCH,
0^,NH COOCH,
Q ^ n  /_>h- nW 1'^ '"Wh-
0 NH COOCH,
1*"V-COOCH,
H.COOC
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FC2O0.5
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Q r V ) ^ ^ C O O N a  
H COONa
Na‘
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sa lt
0 ^N^ 'COON.
h y-N .
® N^V^COON.
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N»OOC
\ y^-COOI*i
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4.4.1. Relative Fluorescence Intensity by comparison to 
standard Fluorescein salt.
The compounds under study were prepared as solutions in distillate H2O at 
concentrations that give a UV absorbance value o f 0.1 x 10'5. Compounds (FC2G0.5 
salt, FC2G1.5 salt and FC2G2.5 salt) were excited at UV max wavelength 445 nm 
while Fluorescein salt was excited at UV max wavelength 481 nm. Standard 10 mm 
path length fluorescence cuvette was used for running the fluorescence measurements 
with the concentration range never exceeding an effective adsorption o f 0.1 at the 
maximum excitation wavelength. In order to minimise re-absorption effects (Dhami et 
al.),[2331 the fluorescence spectra o f  all compounds were determined under the same 
operation conditions and settings with 7.5 slit widths. Fluorescence quantum yields 
were determined by comparing the integral areas o f  the fluorescence emission for the 
different compounds.
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3
2r
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cV
8 G 1.5  sa lt
7
G 2 .5  sa lt
6
F lu oresc in e  sa lt
5
G 0.5  sa lt4
3
2
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Figure [4.1]: Fluorescence emission curves for all FC2G0.5, FC2G1.5, FC2G2.5 salts 
(when excited at wavelength Amax 447 nm), and Fluorescein salt (when excited at 
wavelength Amax 481 nm) in H20  at UV absorbance 0.1 x 10 5.
Fluorescine salt
Figure [4.2]: Fluorescence intensity values of all FC2G0.5, FC2G1.5, FC2G2.5 salts 
(when excited at wavelength Xmax 447 nm), and Fluorescein salt (when excited at 
wavelength Xmax 481 nm ) in H20  at UV absorbance 0.1 x 10'5.
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5.1. Design and synthesis
5.1.1. Synthesis of new fluorescent dendritic wedges.
The new fluorescent cores described in this thesis were designed to possess specific 
features including (a) functional groups to build up multi PAMAM dendritic wadges, 
(b) high fluorescence emission and (c) biologically activity especially for DNA 
intercalation, anticancer activity, and/or as special protein binding inhibitor. Further 
examples that could be used for this purpose are given in (Scheme 5.1).
FC3 EC4
-
HOOC
Br
FC4 G2.5
COOH
COOH
COOH
°*^NH
COOH
O nh COOH
COOH
HOOC
Scheme [5.1]: New fluorescent cores FC3, FC4, FC5 and an example of a new 
fluorescent PAMAM dendritic wedge FC4G2.5.
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5.1.2 Synthesis of fluorescent PAMAM dendritic multi­
wedges.
The cores FC3 and FC5 can be used to prepare bow-tie dendrimers. For example, 
FC3G2.5 and FC5G2.5 can be prepared by a divergent pathway. Similarly, compound 
FC5G2.5 can be prepared via a convergent method; this route gives more facility to 
loading different dendritic wedges or different conjugated moieties (Figure 5.1).
CO O H
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H OO C
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H OOC
H OO C
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N W /  H
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C O O H
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Figure [5.1]: New fluorescent PAMAM dendritic double wedges FC3G2.5, FC5G2.5
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5.1.3 Self assembled core of fluorescent PAMAM Dendritic 
wedges.
Dendron self assembly can result from weak noncovalent interactions (e.g. van der 
Waals, hydrophobic forces, 7C — 7C interactions, hydrogen bonds) as opposed to more
"classical" covalent, ionic or metallic bonds. It would be o f  interest to use 
intermolecular self-assembly to form a supradendrimer assembly (Figure 5.3) with
enhanced fluorescence emission. O f particular interest will be the use o f 71 — 71 
interactions and hydrogen bonding for self-assembly.
COONa
NaOOC NaOOC
COONa
COONa
NaOOC u / — N,
COONa
NaOOC
COONa
COONa
COONa
NaOOC
N H COONa
NaOOC ^  '
COONa
SCOONa
Assembling 
Core
COONa
NaOOC
NaOOC
NaOOC
COONa
COONa
COONa
 COONa
s „ H ° ' " ' v>~N s
O \ COONa
0U H V n - 
NH
COONa
COONa
NaOOC
COONa
\ COONa 
NaOOC
Figure [5.2]: Possible structure for self assembly fluorescent core dendrimer.
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For example, melamine-based systems compounds are proven H-bonding units that 
have been used for the self assembly o f fluorescent core derived from naphthalene 
derivatives (Scheme 5.3).[235] We are more interested in n-n interactions because they 
act strongly on flat polycyclic aromatic hydrocarbons such those uses for fluorescent
cores.
R
R
11
H -N
H -N
> = N  R 
N /)—N
y — N R
12
0 - - H - N
N - H  N,
\ 0 — H - N
R = 2- Et-Hexan
Scheme [5.3]: Formation of a hydrogen bonded complex of 1 :1 stoichiometry 
between the monotopic naphthalene bisimide 11 and melamine 12.
5.2 Chemotherapeutic applications
Through new and continued co-operation with other research groups, we would be 
interested in developing the applications o f  our fluorescent dendron in the following 
areas.
5.2.1 Inhibitor of protein aggregation.
Some diseases are related to large insoluble protein aggregates resulting from 
abnormal protein folding and protein binding behaviour. Twyman’s group have 
recently developed a dendrimer-based methodology for studying the various 
contributing factors to protein-protein interactions instead o f  the conventional small 
molecule approach.[236^ For example it was found that PAMAM dendrimers bind more 
strongly to proteins o f  similar size (e.g. cytochrome-c to G2 and PAMAM
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chymotrypsin to G3 PAMAM) (Figure 5.4) so that the dendrimer that binds best has a 
maximum addressable area o f  similar dimensions to the interfacial area o f  the 
protein.1291
Dend rimers 1
(G o j“~OH)4 ( g ^ C 01^
1S0A2 800A 2 1200A2
Target^ro fe ins^
22S0A2
Figure [5.4]: Schematic showing the relative size of PAMAM dendrimers and 
proteins used for binding studies. The maximum addressable and interfacial 
areas are shown below each dendrimer and protein respectively.1291
A similar methodology could be applied to the same two proteins but by using 
different generations o f  our fluorescent PAMAM dendritic systems terminated with -  
COOH or NH2 (Figure 5.5) to be used as a protein inhibitor and biosensor 
simultaneously.
3200A2
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Figure [5.5]: Fluorescent poly(amidoamine) (PAMAM) dendrons (FC2G0 - FC2G2.5)
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5.2.2. Anticancer activity studies.
Recently, much effort has been made by researchers to discover and produce new 
anticancer drugs with no undesirable side effects.[23?1 DNA intercalators are new 
potential anticancer agents,tl841 which are mostly described as planar heterocyclic 
molecules with approximately the same size and shape o f  a DNA base pair.[2381 DNA 
intercalators interact with DNA by inserting perpendicularly into DNA and their 
stability depends on van der Waals, hydrophobic, hydrogen bonding, and charge 
transfer forces.12391 The results o f this interaction can cause disfiguration o f  the DNA 
double helix, affecting the process o f  cell replication and leading to cellular passing 
away and special genotoxic effects.[2401
There are very strong interactions between protonated polyamines and DNA 
phosphate residues;t2411 hence there are many examples o f naphthalimmide derivatives 
as anticancer agents^184"1881 These examples are where the aromatic system is inserted 
between the DNA base pairs whilst the protonated amine base interacts with 
grooves.[242] Compounds Mitonafide and Amonafide (Figure 5.6) are the most famous 
trial compounds o f  the naphthalimmide series for anticancer activity, but they are 
highly toxic.[I89' 1901 Hence, the desire for analogues.1243’2451
KjN
N - H
Mitonafide Amonafide
Figure [5.6]: Chemical structures o f compound Mitonafide and Amonafide.
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Derivatives o f  naphthalimide and naphthalimide polyamine conjugates are currently 
under investigation for use as anti-tumor agents.|246] Due to the strong interactions 
between DNA and protonated polyamines, many interesting assemblages o f  
polyamines and DNA intercalators can be employed as linear,[247'248] m acrocyclic/2491 
or dendronic polyamines.[I4I]
Dendritic polyamine-(imide-DNA intercalator) conjugates have been modified to 
conjugate naphthalimide derivatives with the chromophore as antitumour compound 
(Figure 5.7).[14l]
Compound B Compound A
nh2
Figure [5.7]: Compound A: "PAMAM dendritic polyamines-(imide-DNA 
intercalator)" conjugates, Compound B: "PPI dendritic polyamines-(imide-DNA
intercalator)".[141]
The PAMAM dendritic wedges that contain fluorescent cores studied in this project 
have yet to be investigated for this application. Thus, the pharmacological activity o f  
such compounds could be significant, especially they show strong DNA binding.t246]
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Appendix A: Chemotherapeutic Applications
All o f  the following work was accomplished by internal collaborations within Cardiff 
University. The “in-vitro permeability study” was carried out by PhD student Ghaith 
Al-Jayyouss o f  the group o f Dr. Mark Gumbleton (Welsh School o f  Pharmacy), while 
the “DNA binding study” was performed by PhD students Irina Dorin and Ismail 
Althagafi o f  the group o f Dr. Niek Buurma (School o f  Chemistry).
A.1. In-Vitro Permeability Studies 
A .1.1. In troduction
The rate o f  permeability o f positively charged dendrimers o f different generations 
across epithelial cell monolayers depends on their concentration, and on the 
generation; with the order o f  permeability being reported as G4 > G 0  ~ G1 > G3 > 
G2P 1' 250] In addition to the generation size o f  the dendrimer, also the charge o f  
peripheral groups o f  the dendrimer surface effects the efficiency o f  dendrimer 
transport, presumably by modulating the intercellular tight junctions. It is believed 
that adsorptive-mediated endocytosis is the probable mechanism o f  dendrimer 
transport across epithelial cells.[251] Recent studies by D ’Emanuele et al. confirmed 
that conjugation o f  small molecular weight drugs (that are known to be p-glycoprotein 
[P-gp] substrates) to PAMAM dendrimers enhances their transport across P-gp 
expressing cells indicating that dendrimers are themselves not substrates for P-gp and 
that they can carry cargo into cells bypassing the plasma membrane P-gp efflux.
Recently, many reports have verified that the transport o f  PAMAM dendrimers across 
the epithelial barrier o f the gut is influenced by the surface chemistry o f the 
dendrimers. t26'28] Early studies propose that the way in which both cationic[27] and 
anionic[26,28] charged dendrimers leak across epithelial barriers is related to their size. 
In case o f  PAMAM dendrimers terminated with -NH2, transepithelial electrical
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resistance (TEER) readings decreased and l4C-mannitol increased as the generation 
dendrimer increased. In contrast, TEER or 14C-mannitol transport was not influenced 
by PAMAM dendrimers terminated with OH groups; while, in case o f  PAMAM 
dendrimers terminated-COOH, decreased TEER and increased l4C-mannitol 
permeability within dendrimer generation size (G2.5 and G3.5).[27'28] These studies 
point to an optimum size and charge o f  PAMAM dendrimers that can effectively 
translocation drug molecules across the epithelial barrier o f the gut. Conversely, a 
systematic correlation between the effect o f charge, size, and degree o f  surface 
modification o f these dendrimers on their permeability across the intestinal barrier has 
not been assessed.
The main purpose o f our studies is to investigate the transport o f our series o f 
fluorescent poly(amidoamine) (PAMAM) dendrons (FC2G0.5, FC2G1.5 and FC2G2.5) 
all with negatively charged surface groups across cell barriers. A test system for 
measuring membrane permeability has been developed using the MDCK (M adin- 
Darby Canine Kidney) cell line, to mimic the distal renal epithelium o f  a normal male 
cocker spaniel.[252] In case o f inertly absorbed compounds, drug permeability across 
MDCK cells is analogous to permeability across Caco-2 cells.[252] Over 2 -6  days, 
confluent MDCK monolayers form a tight junction network visible by confocal 
microscopy.[253] The cell lines used are similar except that they hold different numbers 
o f tight junctions, such that their intercellular restrictiveness is different. For instance, 
the MDCK I cell line present high restrictiveness, e.g. TEER o f 2000 D.crn2, while 
the MDCK II cell line is more permeable with a TEER o f 200 f lc m 2; therefore, 
MDCK I is frequently used as a permeability model for the Blood Brain Barrier 
(BBB) while the MDCK II a model for the more permeable intestinal barrier.
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A.1.2. Results and Discussions
A .1.2.1. Permeability of fluorescent core PAMAM dendrons across MDCK I, II 
cell monolayers
MDCK I, II cells were seeded at 45,000 cells/cm2 onto polyester 24-well Transwell® 
filters o f  0.8 pm mean pore size, 0.33 cm surface area (Coming Incorporated, 
Coming, NY). MDCK I, II cells were maintained under appropriate incubation 
conditions described above and used for transport experiments after 4 days post- 
seeding. The transport o f fluorescent core PAMAM dendrons was investigated in 
triplicate in the apical-to-basolateral (A-B) direction (Figure A .l) at a donor 
concentration o f l.O mM. Permeability experiments were conducted in a humidified
o
atmosphere o f 37 C. Samples were collected from the receiver chamber at 30, 60, 90 
and 120 min. Permeability samples were analyzed using a Fluostar fluorometer with 
fluorescent-core PAMAM dendron samples being detected with an excitation
Transwell
insert
Apical
chamberCell —  
monolayer
Permeable
membrane
-  Basolateral 
3 chamber
Figure [A.l]: Schematic of a Transwelf insert showing the separation of apical and 
basolateral chambers by a permeable membrane with a confluent cell monolayer on
the apical surface.12541
wavelength o f 460 nm and an emission wavelength o f  540 nm. The apparent 
permeability (Papp) coefficients were calculated as follows:
Appendix A: Chemotherapeutic Applications
Where A is the surface area o f  the membrane filter, Co is the initial concentration in 
the donor chamber, and dQ/dt is the permeability rate.12551
For MDCK I cell line, Papp to flourescent PAMAM dendron FC2G0.5 salt {Vapp 
1.81 ±0.17 xlO-6 cm .sec'1) was significantly higher than the maximum possible ? app 
(based upon LLQ) for FC2G1.5 salt o f  Papp < 0.58 xlO-6 cm .sec'11 and for FC2G2.5 salt 
o f  Paf>P < 0.35 xlO'6 cm.sec’1 (Table 1). Similarly a decrease in Papp with increase in 
molecular size was observed for the MDCK II cell line where Papp o f  flourescent 
PAMAM dendron FC2G0.5 salt (Papp 8.93±2.1 xlO-6 cm.sec'1) was significantly 
greater than FC2G1.5 salt (Papp 1.38±0.24 xlO'6 cm.sec'1) and FC2G2.5 salt where the 
maximum possible PapP (based upon LLQ) was xlO'6 cm .sec'1 (Table A .l; Figure
A.2).
Table [A.l]: Permeability Coefficient (lO -6 cm.s'1) for dendron generations across 
_______________________________ MDCK I, II cell lines._____________________________
Papp (MDCK I) Papp (MDCK II)
D endron xlO’6 cm.s’1 xlO '6 cm .s'1
FC2G0.5 salt 1.81 ±0.17 8.93 ±2.1
FC2G1.5 salt BLQ  < 0.58 1.38 ±0.24
FC2G2.5 salt BLQ  < 0.35 BLQ  <3.48
The correlation between monolayer permeability (Papp) and TEER values with the 
PAMAM dendrons allows us to speculate that these fluorescent dendrons might have 
been transported across the epithelial cells via a paracellular route. The permeabilities 
o f  the dendrons across MDCK II cell line are higher over the permeability across 
MDCK I cell line was attributed to differences in restrictiveness where MDCK I cell 
line is more restrictive than MDCK II cell line due to the existence o f  greater 
concentration o f  tight junctions.[256]
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12 1
BLQ BLQ
■ MDCK I
■ MDCK II
GO. 5 G1.5
Fluorescent PAMAM dendron generation
G2.5
Figure [A.2]: The permeability of Fluorescent PAMAM dendrons across MDCK I, II 
cell monolayer in AB (apical-to-basolateral) directions at concentration Im M .
A .1.2.2. Effect on monolayer integrity by measuring transepithelial electrical 
resistance (TEER)
MDCK I, II cells (passages 5-30) were seeded onto the polystyrene 24-well 
Transwell® filters at a density o f  l x 105 cells/cm2. The cells were grown at 37 °C in an 
atmosphere o f  5% CO2 and 95% relative humidity. Cells were maintained in T-75 
flasks using Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% 
fetal bovine serum, 10,000 units/ml penicillin, 10,000 pg/ml streptomycin. Growth 
medium was changed every 2 days. Cells were passaged at 70-90% confluency using 
0.25% trypsin/ethylenediamine tetraacetic acid (EDTA) solution. Transport medium 
consisted o f DMEM-F12 invetrogen. Mean TEER value across the MDCK cell 
monolayers was found to be 1000±58 Q.cm2. The effect o f modified fluorescent core 
PAMAM dendrons on two MDCK cell lines monolayers was determined by 
measuring o f  the transepithelial electrical resistance across MDCK cells monolayers 
in presence o f  the fluorescent dendrons at donor concentrations o f lpg/mL and 10
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pg/mL upon both apical and basolateral incubation. The cell monolayer integrity was 
monitored using an epithelial voltohmmeter (EVOM™) to measure the TEER (Trans- 
Epithelial Electrical Resistance) at t = 0 and 120 min.
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Figure [A.3]: The effect of Im M  fluorescent PAMAM FC2G0.5 salt, FC2G1.5 salt or 
FC2G2.5 salt on (MDCK I) monolayer integrity as exhibited by their effect on the 
trans epithelial electrical resistance (TEER) at 0 ,1 2 0  min.
For both MDCK I and MDCK II cell line, the TEER studies indicate that the presence 
o f  any o f  the three fluorescent PAMAM dendrons does significantly change the TEER 
values. The constant TEER value was independent o f dendrimer concentration and 
duration o f  incubation (Figures A.3, A.4).
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■  0 min MDCK II
■  120 min MDCK II
G0.5 G1.5 G2.5
F lu o r esc en t PAMAM d en d ro n  g e n e ra t io n
Figure [A.4]: The effect of Im M  fluorescent PAMAM FC2G0.5 salt, FC2G1.5 salt or 
FC2G2.5 salt on (MDCK II) monolayer integrity as exhibited by their effect on the 
trans epithelial electrical resistance (TEER) at 0, 120 min.
A .1.3. Sum m ary
In conclusion the results o f this initial study suggest that the permeability o f  
fluorescent core PAMAM dendrons across MDCK cell monolayers appear to be a 
function o f the size o f  the dendrons. These studies pave the way for future detailed 
mechanistic and morphological studies to elucidate the nature o f the interaction o f 
fluorescent core PAMAM dendrons with epithelial cells.
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A.2. DNA binding studies 
A .2.1. Introduction
There is very strong binding between the phosphate groups o f  DNA and protonated 
polyamines in acidic media.[2411 These basic groups can decorate a planar, 
intercalating moiety which conjugates with the aromatic system between the base 
pairs, while the basic groups interact with negatively charged phosphate groups 
decorating the surface o f the DNA grooves.[242] A literature survey indicates that there 
are several examples o f  naphthalimide derivatives as intercalating and anticancer 
agents. [184’188]
Poly(amido amine) PAMAM dendrimers are one o f  the universal cationic polymer 
agents that bind to DNA by electrostatic interactions,t257'258] once bound PAMAM 
dendrimers supply protection against DNase activity and hinder gene expression in 
vitro.[259"260] Dendrimers have been applied in DNA binding and gene therapy[261’262] 
and the modification o f  PAMAM dendrons to incorporate a DNA intercalating 
naphthalimide chromophore within its core as to provide anti-tumour activity has been 
described1141] and an interesting pharmacological profile was discovered.
The aim o f  this study is to evaluate PAMAM dendrons/DNA interaction as a function 
o f generation and charge density (cationic, neutral), in order to interrogate the 
characteristics o f  the binding event. For this purpose we have investigated the binding 
o f  a calf thymus DNA sample, fluorescent -COOH terminated PAMAM dendrons o f  
generation FC2G0.5, FC2G2.5 and FC2G0, and -N H 2 terminated FC2G1, FC2G2 
PAMAM dendrons using UV-visible spectroscopy.
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A.2.2. Results and discussion
The DNA-binding properties o f 3 -bromo- 7//-benz[<7e]benzimidazo[2,1- 
<2]isoquinoline-7-one FC2 and its dendritic derivatives o f  different generations were 
studied using UV-visible titrations. Unfortunately, the aqueous solubility o f  FC2 is 
negligible, which did not allow us to carry out UV-visible titrations. Aqueous 
solubility o f  FC2G0, however, is sufficient for UV-visible titrations (Figure A.5).
15000-
|  10000-
TJ
5000
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x / n m
Figure [A.5]: UV-visible spectra for 2.69 x 10' mM FC2G0 upon addition of 0 -  1.29 
mM calf thymus DNA in 25 mM MOPS pH 7.0, 50 mM NaCI and 1 mM EDTA, at 25 °C.
Figure (A.5) shows an increase in extinction coefficient with increasing concentration 
o f DNA, eventually leading to a spectrum with maxima at 446 and 463 nm. A titration 
curve can be extracted from the data (Figure A. 6).
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Figure [A.6]: UV-visible absorbance at 446 and 463 nm for 2.69 x 10'2 mM FC2G0 
upon addition of 0 -  1.29 mM calf thymus DNA in 25 mM MOPS pH 7.0, 50 mM NaCI 
and 1 mM EDTA, at 25 °C. Red lines are fits to a multiple independent binding sites
model.
Figures (A.5) and (A.6) show clear change in the UV-visible spectrum o f FC2G0 upon 
addition o f  calf thymus DNA. Data can be analysed in terms o f  a multiple 
independent binding sites model, but the derived parameters suggest a problem with 
calculated concentrations (the model suggests that 10 ligand molecules bind to every 
base pair, which is unrealistic). In any case, DNA binding o f FC2G0 is relatively 
strong.
To investigate the effect o f covalently-attached negatively-charged dendrimeric 
structures, we studied the interactions with calf thymus DNA o f FC2G0.5 carboxylate 
salt and FC2G2.5 carboxylate salt, again using UV-visible titrations (Figures A.7 and 
A.8).
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Figure [A.7]: UV-visible spectra for 3.76 x 10'2 mM FC2G0.5 salt upon addition of 0 -  
3.03 mM calf thymus DNA in 25 mM MOPS pH 7.0, 50 mM NaCI and 1 mM EDTA, at
25 °C.
Figure (A.7) shows a small increase in the extinction coefficient for FC2G0.5 
carboxylate upon addition o f calf thymus DNA. The increase in extinction coefficient 
does not reach saturation even in the presence o f 3.03 mM calf thymus DNA, 
indicating that the interaction o f FC2G0.5 with calf thymus DNA is considerably 
weaker than the interaction o f FC2G0 with calf thymus DNA. Nevertheless, the 
change in the absorption peak towards a shape reminiscent o f that for fully DNA- 
bound FC2G0 suggests that both molecules bind to DNA in a similar manner, but that 
binding is attenuated by the appended dendron. Both electrostatic and steric repulsion 
will undoubtedly play a role.
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Figure [A.8]: UV-visible spectra for 4.98 x 10'2 mM FC2G2.5 salt upon addition of 0 -  
4.44 mM calf thymus DNA in 25 mM MOPS pH 7.0, 50 mM NaCI and 1 mM EDTA, at
25 °C.
Figure (A.8) does not show increases in extinction coefficients. A small decrease in 
extinction coefficient is observed but this does not reach saturation: binding is weak, 
if any binding occurs at all.
To check whether binding could be switched back on by eliminating electrostatic 
repulsion, the interaction with DNA o f FC2G2.5 ester was studied (Figure A.9)
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Figure [A.9]: UV-visible spectra for 2.49 x 10'2 mM FC2G2.5 ester upon addition of 0 
- 0 .2 6  mM calf thymus DNA in 25 mM MOPS pH 7.0, 50 mM NaCI and 1 mM EDTA, at
25 °C.
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Figure (A.9) again shows a small decrease in extinction coefficients and saturation is 
not reached. This indicates that binding is again weak, if occurring at all. Eliminating 
electrostatic repulsion has not restored DNA binding. We therefore conclude that 
steric repulsion between the dendrons and the DNA contributes to the lack o f 
observable interactions between the fluorescent core and DNA.
To investigate the effect o f covalently-attached positively-charged dendrimeric 
structures, the interactions with calf thymus DNA o f FC2G1 and FC2G2 were studied 
using UV-visible titrations (Figures A. 10 and A .l 1).
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Figure [A.10]: UV-visible spectra for 3.77 x 1 0 2 mM FC2G1 amine upon addition of 0 
-  1.38 mM calf thymus DNA in 25 mM MOPS pH 7.0, 50 mM NaCI and 1 mM EDTA, at
25 °C.
Figure (A. 10) shows an increase in absorbance upon addition o f calf thymus DNA, 
but in this case, addition o f  DNA also leads to precipitation. We attribute this to 
strong binding o f  FC2G1 to calf thymus DNA, eventually resulting in charge 
neutralization in the FC2G1-DNA complex, which result in its precipitation.
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Figure [A.11]: UV-visible spectra for 2.09 x 1 0 2 mM FC2G2 polyamine upon addition 
of 0 - 5 .2  mM calf thymus DNA in 25 mM MOPS pH 7.0, 50 mM NaCI and 1 mM
EDTA, at 25 °C.
Figure (A. 11) similarly shows an increase in absorbance. Precipitation is also 
observed for the FC2G2-DNA complex and is clear from the increase in baseline 
absorbance as a result o f scattering particles.
A .2.3. Sum m ary
The fluorescent core binds to DNA. Although we have not done any experiments to 
elucidate the binding mode, one would expect this type o f  flat aromatic molecule to be 
an intercalator. Addition o f  negatively charged dendrons results in a strong decrease 
in affinity for DNA. The affinity is not restored by esterification, highlighting 
contributions o f  both electrostatic repulsion but particularly steric interactions in 
blocking interactions. Coupling the fluorescent core to positively charged dendrons 
leads to strong binding accompanied by precipitation o f the DNA complex. The latter 
observation is in line with the literature.1141,257'258,261‘262]
